Turn this list into an evaluation

Each entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.

Prepare with a buyer guide:

Clinical guide links appear when this list contains a current reviewed example. They do not classify or endorse the other entries. All buyer guides · Compare exact records · Documented families

FDA-cleared K253969

ADAS 3D

Adas3D Medical S.L.

Authorized purpose: ADAS 3D supports visualization and analysis of MR and CT images of the heart for individual patients with cardiovascular disease, including patients with myocardial scar from ischemic or non-ischemic heart disease. Qualified professionals may use it for cardiac calculation, quantification, visualization, pre-planning, and electrophysiology procedures; produced data support clinical decision-making and must not be used as irrefutable medical advice or for radiotherapy planning, dose calculation, or treatment delivery.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Heart; myocardial scar and cardiac structures
Decision
2026-06-29
FDA-cleared K260316

CMN Capillary Function with Oncology Virtual Expert

Cercare Medical A/S

Authorized purpose: Cercare Neurosuite with Capillary Function and Oncology Virtual Expert processes CT or MR information to provide perfusion, tissue-blood-volume, diffusion, labeling, and quantification support for adult brain glioma workflows.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Brain
Decision
2026-06-22
FDA-cleared K261713

Synapse PACS (7.6.0)

FUJIFILM Healthcare Americas Corporation

Synapse PACS 7.6.0 provides medical-image management and processing, including measurements, regional segmentation, clinical calculations, structured reports, comparison, fusion, and volume rendering to aid reading, interpretation, reporting, and treatment planning.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
N/A
Decision
2026-06-18
FDA-cleared K260406

Brainomix 360 Hyperdensity

Brainomix Limited

Authorized purpose: Provides volumetric hyperdensity segmentation and quantification as an aid; physicians must review original images.

Modality
CT/CTA
Anatomy
Brain
Decision
2026-06-12
FDA-cleared K260322

Acorn 3D Software (AC-SEG-4009); Acorn 3DP Model (AC-101-XX)

Mighty Oak Medical

Authorized purpose: Acorn 3D Software and Acorn 3DP Model process CT, synthetic CT, and CT angiography for segmentation, visualization, measurement, treatment planning, and three-dimensional printing, including adult and pediatric spine trajectory planning.

Modality
CT/CTA
Anatomy
Spine; craniomaxillofacial; musculoskeletal anatomy; and patient-specific printed models
Decision
2026-06-11
FDA-cleared K261405

ANDI 2.2

Imeka Solutions, Inc.

Authorized purpose: ANDI 2.2 processes brain MR images for atlas-assisted visualization, segmentation and volumetric quantification, presenting adjunctive DICOM-readable information for trained medical professionals; it does not predict, diagnose or interpret brain health.

Modality
MRI
Anatomy
Brain
Decision
2026-05-28
FDA-cleared K252563

Neurophet SCALE PET

Neurophet., Inc.

Authorized purpose: Brain MRI/PET registration, segmentation and quantitative PET assessment

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Brain
Decision
2026-05-15
FDA-cleared K261273

Neurophet AQUA

Neurophet., Inc.

Authorized purpose: Neurophet AQUA is intended for automatic labeling, visualization, and volumetric quantification of segmentable brain structures and lesions from a set of MR images; volumetric data may be compared to reference percentile data.

Modality
MRI
Anatomy
Brain; segmentable structures and lesions
Decision
2026-05-15
FDA-cleared K261289

UNiD™ Spine Analyzer (SW3002)

Medicrea International S.A.S. (Medtronic)

Authorized purpose: UNiD Spine Analyzer SW3002 v5.1.0 enables healthcare professionals to view and measure images and plan orthopedic spine surgeries, including preoperative and postoperative measurements and patient-specific rod or implant planning.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Spine
Decision
2026-05-15
FDA-cleared K260032

Morph

BeauBrain Healthcare, Inc.

Authorized purpose: Morph automatically labels, visualizes, and volumetrically quantifies segmentable brain structures from MR images and may compare measurements with reference percentile data; it is adjunctive and not the sole basis for final decisions.

Modality
MRI
Anatomy
Brain
Decision
2026-05-13
FDA-cleared K254189

Synapse 3D Base Tools (V7.2)

Fujifilm Corporation

Authorized purpose: Fujifilm Synapse 3D Base Tools V7.2 provides trained professionals with two-dimensional, three-dimensional, multiplanar, and related viewing, measurement, and analysis functions for the supported DICOM studies.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Whole body and modality-specific anatomy represented in CT, MR, CR, US, NM, PT, and XA studies
Decision
2026-04-30
FDA-cleared K253459

OPTIS Mobile Next Imaging System (1014932); OPTIS Integrated Next Imaging System (1014933); Ultreon 3.0 Software Upgrade Kit (ULTR300001)

ABBOTT MEDICAL

Authorized purpose: Abbott OPTIS Mobile or Integrated Next with Ultreon 3.0 processes compatible coronary intravascular OCT data to support visualization, measurement, and interventional assessment of coronary vessels.

Modality
Optical Coherence Tomography
Anatomy
Coronary arteries
Decision
2026-04-24
FDA-cleared K260785

DS Core CBCT Anatomy

Dentsply Sirona

Authorized purpose: DS Core CBCT Anatomy uses CBCT and digital-impression data to provide tooth and jaw segmentation, inferior-alveolar-nerve-canal segmentation, panoramic-curve support, and registration for dental professionals.

Modality
CBCT
Anatomy
Teeth; jaws; and the inferior alveolar nerve canal
Decision
2026-04-23
FDA-cleared K252237

EdgeFlow UW20

Edgecare, Inc.

Authorized purpose: EdgeFlow UW20 is a wearable ultrasound system for noninvasive periodic bladder-volume measurement in adults with BMI no greater than 30.

Modality
Ultrasound
Anatomy
Urinary bladder
Decision
2026-04-17
FDA-cleared K254015

CoLumbo C-Spine

Smart Soft Healthcare AD

Authorized purpose: Post-process previously acquired cervical-spine MR images to segment vertebrae and disks, calculate quantitative measurements, label out-of-range values, and export results for user review and interpretation.

Modality
MRI
Anatomy
Cervical spine: vertebrae C3-C7 and disks C2C3 through C7T1
Decision
2026-04-01
FDA-cleared K253270

Contour ProtégéAI+

Mim Software, Inc.

Authorized purpose: Contour ProtégéAI+ processes CT and MR DICOM images and generates contours for quantitative analysis, adaptive therapy, image registration, transfer to radiotherapy planning, and archiving subject to qualified review and editing.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Multi-region
Decision
2026-03-27
FDA-cleared K253944

Data Analysis Facilitation Suite (DAFS)

Voronoi Health Analytics Incorporated

Authorized purpose: DAFS automatically segments anatomy on DICOM Part 10 CT images and supports reviewed two- and three-dimensional visualization, editing, and area, volume, and intensity measurements; it does not provide diagnostic interpretation.

Modality
CT/CTA
Anatomy
Multi-region
Decision
2026-03-16
FDA-cleared K252261

InferCare RECIST

Beijing Infervision Healthcare Medical Technology Co., Ltd.

Authorized purpose: InferCare RECIST is a post-processing application for longitudinal medical-image display, lesion measurement, registration, tracking, segmentation, three-dimensional reconstruction, and RECIST reporting by trained professionals.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Tumors and lesions in adult patients age 21 and older
Decision
2026-03-13
FDA-cleared K253413

LiverMultiScan (v6.0)

Perspectum, Ltd.

Authorized purpose: LiverMultiScan v6.0 is MR diagnostic software for non-invasive liver-health assessment that generates, displays, and supports review of MR data and quantitative cT1, PDFF, and LIC metrics or composite images for trained healthcare-professional interpretation.

Modality
MRI
Anatomy
Liver
Decision
2026-03-09
FDA-cleared K253551

VELYS™ Hip Navigation

Depuy Ireland UC

Authorized purpose: VELYS Hip Navigation analyzes intraoperative X-ray or fluoroscopy for total hip arthroplasty with surgeon-confirmed landmark suggestions and measurements of cup orientation, leg length, offset, and implant constructs.

Modality
Fluoroscopy/Angiography
Anatomy
Hip
Decision
2026-03-06
FDA-cleared K252538

CEPHX3D

Orca Dental AI, Ltd.

Authorized purpose: CEPHX3D processes dental and craniomaxillofacial images to support diagnosis and treatment planning, including three-dimensional models, viewing, segmentation, measurements, and dental-solution design input for patients age 12 and older.

Modality
CBCT
Anatomy
Dental and craniomaxillofacial anatomy
Decision
2026-03-05
FDA-cleared K253535

Ligence Heart

Ligence Uab

Ligence Heart is a fully automated software platform that processes, analyses and makes measurements on acquired transthoracic cardiac ultrasound images, automatically producing a full report with measurements of several key cardiac structural and functional parameters. The data produced by this software is intended to be used to support qualified cardiologists or sonographers for clinical decision making. Ligence Heart is indicated for use in adult patients. Ligence Heart has not been validated for the assessment of congenital heart disease, valve disease, pericardial disease, and/or intra-cardiac lesions (e.g., tumors, thrombi). Limitations: Poor image capture will lead to poor annotations and subsequent measurements. Multiple image quality algorithms are used to filter out images of poor quality. Our software complements good patient care and does not exempt the user from the responsibility to provide supervision, clinically review the patient, and make appropriate clinical decisions. If no gender is present, female referenced guideline values will be used for conclusions. If Body Surface Area (BSA) is not present, indexed values cannot be provided. During image acquisition, inappropriate use of the echo machine, use of non-cardiac ultrasound probes, or use of suboptimal settings (e.g., gain, contrast, depth) may lead to lower accuracy of the software. Ligence Heart has not been validated in patients with prosthetic or surgically altered cardiac valves, implantable intracardiac devices, or irregular (non-sinus) rhythm; these conditions may affect automated measurement accuracy.

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2026-02-27
FDA-cleared K252500

CARA System

Cara Medical, Ltd.

Authorized purpose: CARA assists adult structural-heart and conduction-system procedure planning by segmenting preprocedural CT, visualizing cardiac chambers and conduction landmarks, and overlaying a reviewed three-dimensional roadmap on live fluoroscopy.

Modality
Fluoroscopy/Angiography
Anatomy
Heart/Cardiovascular
Decision
2026-02-20
FDA-cleared K252084

AI4CMR v2.0

Ai4medimaging Medical Solutions S.A.

Authorized purpose: Cardiac MRI ventricular function and 2D phase-contrast flow quantification

Modality
MRI
Anatomy
Heart/Cardiovascular
Decision
2026-02-11
FDA-cleared K254016

MI View&GO

Siemens Medical Solutions USA, Inc.

Authorized purpose: MI View&GO is a medical diagnostic application for viewing, manipulating, quantifying, analyzing, and comparing PET, nuclear-medicine, CT, and MR images across one or more time points, including labeled oncology, cardiology, neurology, organ-function, and radiotherapy-planning workflows.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Whole body, organs, tumors, heart, brain, and oncology regions
Decision
2026-02-10
FDA-cleared K251474

Median LCS (internal name) / eyonis LCS (trade name) (1.0)

Median Technologies

eyonis LCS is a concurrent-reading aid for radiologists that detects, localizes, and characterizes 4-30 mm solid and part-solid pulmonary nodules on low-dose chest CT images for high-risk lung cancer screening patients; it provides nodule measurements and malignancy scores and does not replace physician judgment.

Modality
CT/CTA
Anatomy
Chest/Lung
Decision
2026-02-06
FDA-cleared K252091

Surgical Reality Viewer

Medicalvr B.V.

Authorized purpose: Surgical Reality Viewer provides preoperative and intraoperative two-dimensional and three-dimensional visualizations from patient images and normal-anatomy segmentations; machine-learning segmentations are preliminary and require professional review.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Patient-specific surgical anatomy and normal anatomy
Decision
2026-01-29
FDA-cleared K252496

Neurophet AQUA AD Plus

Neurophet., Inc.

Authorized purpose: Quantitative brain MRI and amyloid-PET analysis, including volumetric reference-percentile comparison and SUVR quantification, to support physician clinical evaluation.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Brain
Decision
2026-01-29
FDA-cleared K251351

AccuContour 4.0

Manteia Technologies Co., Ltd.

Authorized purpose: AccuContour 4.0 uses deep-learning contours to support segmentation of organs at risk on CT images for radiation-treatment planning, evaluation, and adaptation; qualified professionals review and may edit the contours.

Modality
Radiotherapy Planning Imaging
Anatomy
Head and neck, thorax, abdomen, and pelvis organs at risk
Decision
2026-01-23
FDA-cleared K253057

AI-Rad Companion Brain MR

Siemens Healthcare GmbH

Authorized purpose: Brain MRI morphometry and white matter hyperintensity quantification, including normative comparison and longitudinal change assessment for clinician review.

Modality
MRI
Anatomy
Brain
Decision
2026-01-22
FDA-cleared K253735

AV Vascular

Philips Medical Systems Nederland B.V.

Authorized purpose: AV Vascular assists trained healthcare professionals with visualization, assessment, and quantification of vascular anatomy on CTA and/or MRA for suspected or diagnosed vascular pathology and pre-procedural endovascular planning.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Vascular anatomy; head/neck, body, aorta, iliac and subclavian vessels
Decision
2026-01-22
FDA-cleared K252634

Imagine® Enterprise Suite

Softlink International Private Limited

Authorized purpose: Imagine Enterprise Suite receives, stores, shares, visualizes, quantifies, and processes images from multiple modalities; MPXA-2000 supports coronary-angiography calculation with automated vessel contours that require review and editing.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Cardiac and coronary anatomy plus multi-modality clinical studies
Decision
2026-01-16
FDA-cleared K252856

PeekMed web

Peek Health, S.A.

Authorized purpose: PeekMed web supports preoperative planning from imported patient imaging with two-dimensional and three-dimensional visualization, measurements, templates, and machine-learning-assisted knee segmentation and landmarking subject to clinician review and approval.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Patient-specific anatomy for preoperative planning, including knee and labeled orthopedic regions
Decision
2025-12-22
FDA-cleared K252029

AI-CVD

HeartLung Corporation

Authorized purpose: AI-CVD provides automated quantitative CT-derived anatomical and density measurements for clinician review, including calcium scores, cardiac and vascular measurements, lung and liver density, bone mineral density, and muscle/fat composition; it is opportunistic decision support, not diagnostic interpretation or risk prediction.

Modality
CT/CTA
Anatomy
Chest, abdomen, heart, lungs, liver, aorta, pulmonary artery, bone, muscle, and fat
Decision
2025-12-19
FDA-cleared K252670

Alzevita

TOPIA MEDTECH LIMITED

Authorized purpose: Automated hippocampal labeling, visualization, and volumetric measurement from high-resolution T1-weighted brain MRI, with comparison to a normative healthy-control dataset acquired using standardized 1.5T/3T protocols.

Modality
MRI
Anatomy
Brain; hippocampus
Decision
2025-12-19
FDA-cleared K250914

MediAI-BA

Crescom Co., Ltd.

Authorized purpose: View and quantify bone age from 2D posteroanterior left-hand radiographs to aid pediatric radiologists assessing patients aged 2-18 years.

Modality
X-ray/Radiography
Anatomy
Left hand and wrist; skeletal maturity/bone age
Decision
2025-12-18
FDA-cleared K252235

PVAD IQ Software

Ultrasight, Ltd.

Authorized purpose: PVAD IQ supports qualified-physician clinical decision support by identifying the aortic annulus and PVAD inlet, calculating their mean distance, and identifying clips acceptable for this measurement.

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2025-12-18
FDA-cleared K252922

Neosoma Brain Mets

Neosoma, Inc.

Authorized purpose: Neosoma Brain Mets semi-automatically segments and contours previously diagnosed brain metastases on T1 post-contrast brain MRI to support radiation-oncology treatment planning.

Modality
MRI
Anatomy
Brain; previously diagnosed brain metastases
Decision
2025-12-17
FDA-cleared K251763

IRISeg

Intuitive Surgical, Inc.

Authorized purpose: IRISeg accepts MR or contrast-enhanced CT images for manual and machine-learning image analysis and segmentation and produces visual three-dimensional models for preoperative planning or intraoperative display; output is non-diagnostic and requires clinician decisions.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Kidneys and other patient-specific surgical anatomy
Decision
2025-12-16
FDA-cleared K251514

Overjet CBCT Assist

Overjet, Inc.

Authorized purpose: Dental and craniomaxillofacial CBCT segmentation, measurement and visualization support

Modality
CBCT
Anatomy
Dental/Maxillofacial
Decision
2025-12-05
FDA-cleared K252103

Acorn 3D Software (AC-SEG-4009); Acorn 3DP Model (AC-101-XX)

Mighty Oak Medical

Authorized purpose: Acorn 3D Software provides modular image processing, visualization, segmentation, measurement, treatment planning, and three-dimensional-printing support; Acorn Trajectory Automation plans pedicle-screw trajectories in adult and pediatric thoracic and lumbar spine cases.

Modality
CT/CTA
Anatomy
Thoracic and lumbar spine, musculoskeletal, craniomaxillofacial, and vascular anatomy
Decision
2025-12-02
FDA-cleared K252217

CT VScore+

Canon Medical Informatics, Inc.

Authorized purpose: CT VScore+ evaluates calcified coronary lesions on ECG-gated, non-contrast cardiac CT in patients aged 30 years or older, automatically generating coronary calcium scores and highlighted calcium segmentation for qualified clinical review.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2025-11-28
FDA-cleared K252086

DTX Studio Assist

Nobel Biocare C/O Medicim NV

Authorized purpose: Analyzes two-dimensional bitewing and periapical radiographs of permanent teeth in patients aged 15 and older to identify and localize caries, calculus, periapical radiolucency, root canal filling deficiency, discrepancy at an existing restoration margin, and bone loss; also supports alveolar bone-level measurement and restoration/dental-anatomy segmentation as an adjunct to dentist review.

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2025-11-17
FDA-cleared K252452

PeekMed web

Peek Health, S.A.

Authorized purpose: PeekMed web supports preoperative planning from imported patient imaging with two-dimensional and three-dimensional visualization, measurements, templates, and machine-learning-assisted knee segmentation and landmarking subject to clinician review and approval.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Patient-specific anatomy for preoperative planning, including knee and labeled orthopedic regions
Decision
2025-11-12
FDA-cleared K250264

SugarBug (1.x)

Bench7, Inc.

Authorized purpose: Provides automated concurrent-read detection and segmentation of caries on bitewing radiographs in patients 18 and older, adding information for the dentist while requiring complete dentist review and judgment.

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2025-11-07
FDA-cleared K250330

3mensio Workstation

Pie Medical Imaging BV

3mensio Workstation is standalone medical-image analysis software for advanced visualization and quantitative analysis of cardiovascular structures. It supports CT, X-ray angiography, and two- and three-dimensional ultrasound DICOM data for planning and sizing cardiovascular interventions, postoperative evaluation, coronary measurements, and calcium scoring.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Heart/Cardiovascular
Decision
2025-11-03
FDA-cleared K251532

Acorn 3D Software (AC-SEG-4009); Acorn 3DP Model (AC-101-XX)

Mighty Oak Medical

Authorized purpose: Acorn 3D Software with Acorn 3DP Model provides modular image processing, visualization, segmentation, measurements, treatment planning, and three-dimensional models, including pedicle-screw trajectory planning for adult and pediatric thoracic and lumbar spine cases.

Modality
CT/CTA
Anatomy
Thoracic and lumbar spine, musculoskeletal, craniomaxillofacial, and vascular anatomy
Decision
2025-11-03
FDA-cleared K250337

AiORTA - Plan

ViTAA Medical Solutions, Inc.

Authorized purpose: AiORTA Plan analyzes cardiovascular CT angiography data to provide volumetric visualization and measurements as adjunctive information for licensed healthcare professionals; it is not intended to be the sole basis for treatment or patient management.

Modality
CT/CTA
Anatomy
Aorta and cardiovascular structures
Decision
2025-10-30
FDA-cleared K251027

cvi42 Coronary Plaque Software Application

Circle Cardiovascular Imaging, Inc.

Authorized purpose: cvi42 Coronary Plaque supports qualified professionals with viewing, post-processing, and qualitative and quantitative evaluation of adult cardiac CT DICOM images to assess the presence and extent of coronary plaques and stenoses in CCTA for CAD or suspected CAD.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2025-10-27
FDA-cleared K251059

Syngo Carbon Clinicals (VA41)

Siemens Healthineers AG

Authorized purpose: Syngo Carbon Clinicals VA41 provides advanced visualization and analysis for clinical images, including OrthoMatic Spine whole-spine curve-angle measurements and TimeLens comparison of regions of interest across time points.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Whole spine and other clinical image regions represented in supported CT and MR workflows
Decision
2025-10-24
FDA-cleared K252298

ANDI 2.0

Imeka Solutions, Inc.

Authorized purpose: Adjunctive quantitative brain MRI analysis that compares patient measures with normative and longitudinal references; a physician reviews all results and makes the clinical decision.

Modality
MRI
Anatomy
Brain
Decision
2025-10-22
FDA-cleared K252665

brAIn™ Shoulder Positioning

Avatar Medical

Authorized purpose: brAIn Shoulder Positioning assists preoperative planning and visualization for primary total shoulder replacement by segmenting and measuring shoulder CT anatomy and supporting manual implant planning.

Modality
CT/CTA
Anatomy
Shoulder, scapula, and humerus
Decision
2025-10-20
FDA-cleared K251355

X1-FFR

Spectrawave, Inc.

Authorized purpose: SpectraWAVE X1-FFR Software segments coronary vessels and reports vessel dimensions, stenosis quantification, and pressure-drop estimates under the supervision of a cardiologist.

Modality
CT/CTA
Anatomy
Coronary arteries
Decision
2025-10-17
FDA-cleared K250766

LungQ 4

Thirona BV

Authorized purpose: Quantitative support for thoracic CT interpretation and treatment planning, including emphysema burden, airway/lung segmentation, endobronchial valve assessment and estimated chronic perfusion defect.

Modality
CT/CTA
Anatomy
Chest/Lung
Decision
2025-10-02
FDA-cleared K250023

SMART PCFD

Disior Ltd

Authorized purpose: SMART PCFD uses algorithms to support orthopedic diagnosis and surgical planning for progressive collapsing foot deformity from weight-bearing CT, including three-dimensional models, measurements, fixation devices, and osteotomy planning.

Modality
CT/CTA
Anatomy
Foot and ankle
Decision
2025-09-29
FDA-cleared K252105

Ligence Heart

Ligence, UAB

Authorized purpose: Automated post-processing and measurement of adult transthoracic echocardiograms to support cardiologist/sonographer review and clinical decision-making.

Modality
Ultrasound
Anatomy
Heart, including left-ventricular structure and function
Decision
2025-09-26
FDA-cleared K251527

Brain WMH

Quantib BV

Authorized purpose: Brain WMH automatically labels, visualizes, and volumetrically quantifies white-matter hyperintensities from T2w FLAIR brain MR and returns segmentations, overlays, and measurements as complementary information for trained professionals and quantitative reporting in the labeled population.

Modality
MRI
Anatomy
Brain; white matter hyperintensities
Decision
2025-09-25
FDA-cleared K251483

SwiftSight-Brain

AIRS Medical Inc.

Authorized purpose: Adjunctive brain MRI morphometry and lesion-quantification support for qualified healthcare professionals, including segmented overlays, volumetric measurements, normative percentiles and longitudinal comparison.

Modality
MRI
Anatomy
Brain
Decision
2025-09-23
FDA-cleared K251987

Rapid Aortic Measurements

iSchemaView, Inc.

Authorized purpose: Aortic and iliac artery segmentation, visualization, measurement, and longitudinal tracking as adjunctive physician decision support.

Modality
CT/CTA
Anatomy
Aorta, iliac arteries, and major branching vessels in the chest, abdomen, and/or pelvis
Decision
2025-09-23
FDA-cleared K250369

Axial3D Insight

Axial Medical Printing Limited

Authorized purpose: Axial3D Insight is a cloud-based image-segmentation service that transfers DICOM images to generate visual models and physical-replica inputs for trauma, orthopedic, maxillofacial, cardiovascular, and treatment-planning workflows; final decisions require expert review.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Trauma, orthopedic, maxillofacial, and cardiovascular anatomy
Decision
2025-09-18
FDA-cleared K251368

FETOLY

Diagnoly

Authorized purpose: FETOLY analyzes fetal ultrasound images and sequences to detect labeled fetal brain and heart views, assess image completeness or quality, and provide fetal biometric measurements during the second and third trimesters.

Modality
Ultrasound
Anatomy
Fetal heart and fetal brain
Decision
2025-09-12
FDA-cleared K251072

Segmentron Viewer

DGNCT, LLC

Authorized purpose: Segmentron Viewer is an AI web application for processing and manipulating maxillofacial radiographic images, viewing and segmenting three-dimensional CBCT data, and creating editable STL outputs for educational use.

Modality
CBCT
Anatomy
Maxillofacial anatomy and permanent dentition
Decision
2025-09-09
FDA-cleared K251682

MuscleView 2.0

Springbok, Inc. (dba Springbok Analytics)

Authorized purpose: Automatic MRI segmentation and quantitative analysis of muscle, bone, fat, and other anatomical structures to assist visualization and measurement; not direct disease diagnosis.

Modality
MRI
Anatomy
Muscles, bones, and adipose tissue across the lower extremities and upper body from neck to hips, plus other segmented structures
Decision
2025-09-09
FDA-cleared K251610

qER-CTA (v1.0)

Qure.ai Technologies

Authorized purpose: Parallel notification of suspected anterior-circulation large vessel occlusion on acute head CTA for specialist review; notification only, not diagnosis.

Modality
CT/CTA
Anatomy
Brain anterior circulation: internal carotid artery and M1 segment of the middle cerebral artery
Decision
2025-09-08
FDA-cleared K251656

Careverse CoronaryDoc (Careverse CoronaryDoc)

Careverse Technology Pte. Ltd.

Authorized purpose: Careverse CoronaryDoc is a web-based tool for trained medical professionals to view and analyze CCTA CT data for coronary plaques and stenosis, with coronary measurements, visualization, automated plaque and stenosis outputs, and structured reporting for physician review.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2025-09-04
FDA-cleared K252539

Tempus Pixel

Arterys, Inc.

Authorized purpose: Multimodality DICOM image management, quantitative analysis, optional cardiovascular MR mapping and flow analysis, and therapy-response lesion tracking for trained clinicians.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Multi-region
Decision
2025-09-03
FDA-cleared K243859

PRAEVAorta®2

Nurea

Authorized purpose: PRAEVAorta 2 assists clinical specialists, physicians, and other licensed practitioners with automatic vascular segmentation and maximum-diameter measurement on adult CT images; results require clinical assessment and physician validation when obtained by a non-physician.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2025-08-29
FDA-cleared K252362

GBrain MRI

Galileo CDS, Inc

Authorized purpose: Post-processing segmentation, quantification, and reporting of brain signal hyperintensities on T2w FLAIR and T1w post-contrast MRI; not detection or specific disease diagnosis.

Modality
MRI
Anatomy
Brain signal hyperintensities
Decision
2025-08-22
FDA-cleared K251837

Salix Coronary Plaque (V1.0.0)

Artrya Limited

Authorized purpose: Salix Coronary Plaque (V1.0.0) is a web-based adjunctive tool for qualified cardiologists and radiologists to quantify and characterize coronary plaque and stenosis and perform calcium scoring from adult cardiac CT DICOM images.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2025-08-20
FDA-cleared K251747

VEA Align; spineEOS

EOS imaging

Authorized purpose: VEA Align is cloud-based software for orthopedic applications in adult and pediatric populations using two-dimensional X-ray images from EOS imaging systems to display interactive landmarks and assess patient-specific global alignment, with angle and length measurements for spinal deformities, degenerative diseases, and lower-limb alignment disorders or deformities. It is suitable for patients aged 7 years and older. spineEOS assists healthcare professionals with preoperative planning of spine surgery using EOS images, associated three-dimensional datasets, measurements, and patient-specific surgical-planning tools.

Modality
X-ray/Radiography
Anatomy
Spine and lower-limb alignment; frontal and lateral EOS images and associated 3D datasets
Decision
2025-08-15
FDA-cleared K251629

UNiD™ Spine Analyzer

Medicrea International S.A.S. (Medtronic)

Authorized purpose: UNiD Spine Analyzer assists healthcare professionals in viewing and measuring images and planning orthopedic spine surgery, including preoperative and postoperative measurements, surgical-strategy simulation, and patient-specific or standard implant planning; clinical judgment and surgeon validation remain required.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Spine
Decision
2025-08-07
FDA-cleared K251322

Venue; Venue Go; Venue Fit; Venue Sprint

GE Medical Systems Ultrasound and Primary care Diagnostics

Authorized purpose: Venue, Venue Go, Venue Fit, and Venue Sprint are general-purpose point-of-care ultrasound systems for trained users across broad adult, pediatric, and neonatal applications, with release-specific AI guidance and measurement functions.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-07-25
FDA-cleared K250686

GyriCalc (Version 1.0.0)

NeuroSpectrum Insights Corp.

Authorized purpose: Adjunctive quantitative brain-mapping report for qualified clinical interpretation of children 24-36 months, providing regional volume, surface-area and local-gyrification measures from 3D T1 MRI.

Modality
MRI
Anatomy
Brain
Decision
2025-07-22
FDA-cleared K251151

Rapid CTA 360

iSchemaView

Authorized purpose: Rapid CTA 360 analyzes adult head CTA DICOM images to flag suspected large- and medium-vessel occlusion in specified intracranial and vertebral segments and notify trained clinicians for workflow triage; notifications are informational and not diagnostic.

Modality
CT/CTA
Anatomy
Brain
Decision
2025-07-16
FDA-cleared K251096

PeekMed web

Peek Health, S.A.

Authorized purpose: PeekMed is a cloud web system for preoperative orthopedic planning from imported X-ray, CT, and MR images, with two-dimensional and three-dimensional visualization, measurements, and prosthetic templates for adults with injury or disability.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Hip; knee; upper limb; foot; and other labeled orthopedic anatomy
Decision
2025-07-14
FDA-cleared K251766

TumorSight Viz

SimBioSys, Inc.

Authorized purpose: TumorSight Viz processes dynamic contrast-enhanced breast MRI for patients with biopsy-proven early-stage or locally advanced breast cancer, providing registration, subtraction, segmentation, 3D renderings, measurements, kinetic curves, parametric maps, MIPs, and reformats for physician visualization and analysis; results are not the sole basis for patient management.

Modality
MRI
Anatomy
Breast
Decision
2025-07-08
FDA-cleared K251528

syngo.via MI Workflows; Scenium; syngo MBF

Siemens Medical Solutions USA, Inc.

Authorized purpose: syngo.via MI Workflows, Scenium, and syngo MBF provide PET, SPECT, nuclear-medicine, CT, and MR viewing, manipulation, quantification, longitudinal comparison, and analysis for oncology, cardiology, neurology, organ function, and selected radiation-planning support.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2025-07-03
FDA-cleared K243647

Synapse PACS (7.5)

FUJIFILM Healthcare Americas Corporation

Authorized purpose: Synapse PACS version 7.5 provides primary processing and presentation of DICOM and supported non-DICOM images with measurement, segmentation, fusion, volume rendering, reporting, integrated 3D, two-point VOI, and AI-assisted bone removal.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Multi-region
Decision
2025-06-30
FDA-cleared K243672

CardIQ Suite

GE Medical Systems SCS

Authorized purpose: CardIQ Suite analyzes 2D or 3D cardiac CT DICOM data for visualization and measurement of cardiovascular anatomy, coronary calcium scoring, coronary review, heart-fat estimation, and treatment or follow-up support under clinician review.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2025-06-18
FDA-cleared K243234

Second Opinion® CS

Pearl Inc.

Authorized purpose: Acts as a CADe second reader to detect and segment caries on periapical radiographs of permanent teeth in patients aged 12 years and older; clinicians review the contours and percentage analysis in context.

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2025-06-12
FDA-cleared K251153

Aurora

GE Medical Systems Israel

Authorized purpose: Aurora is a SPECT/CT system for nuclear-medicine uptake imaging, standalone CT, anatomical localization, attenuation correction, diagnosis, staging, therapy planning, guidance, and monitoring. K251153 adds deep-learning kidney segmentation to dynamic renal scintigraphy.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2025-06-12
FDA-cleared K250354

Viz Subdural+, Viz SUBDURAL PLUS

Viz.ai, Inc.

Authorized purpose: Viz Subdural+ labels, visualizes, and quantifies subdural collections from single-time-point non-contrast head CT, reporting collection grayscale value, total volume, widest width, and midline shift as annotated DICOM images for physician review with original CT.

Modality
CT/CTA
Anatomy
Brain
Decision
2025-06-10
FDA-cleared K243810

TraumaCad Neo (1.1)

Brainlab Ltd.

Authorized purpose: TraumaCad Neo assists healthcare professionals in analyzing orthopedic conditions and planning orthopedic procedures by overlaying measurements and prosthesis templates on relevant radiological images; it is not primary radiological interpretation and clinical judgment remains required.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Hip, knee, upper-limb, and foot orthopedic anatomy represented in X-ray or CT studies
Decision
2025-06-04
FDA-cleared K243005

AudaxCeph Cephalogram Analysis Software

Audax d.o.o.

Authorized purpose: AudaxCeph Cephalogram Analysis Software assists specialized dental practices with storing and presenting patient cephalogram images and treatment planning through landmark digitization, tracing, measurements, superimpositions, and visual treatment objectives; trained and licensed practitioners remain responsible for interpretation.

Modality
X-ray/Radiography
Anatomy
Dental/maxilla/mandible
Decision
2025-05-30
FDA-cleared K243863

Opulus™ Lymphoma Precision

Roche Molecular Systems, Inc.

Authorized purpose: Opulus Lymphoma Precision segments and visualizes lesions and measures total metabolic tumor volume in whole-body FDG-PET/CT for patients already diagnosed with FDG-avid lymphoma; trained physicians can accept/reject annotated output, but radiologist review makes the final interpretation and the device is not a screening/diagnostic substitute.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole-body FDG-PET/CT
Decision
2025-05-30
FDA-cleared K250543

Voluson™ Performance 16; Voluson™ Performance 18

GE Medical Systems Ultrasound and Primary care Diagnostics

Authorized purpose: Voluson Performance 16 and 18 are general-purpose diagnostic ultrasound systems for imaging, measurement, display, and analysis of the human body and fluid across the labeled fetal, obstetric, abdominal, pediatric, small-organ, cephalic, cardiac, vascular, musculoskeletal, lung, and urologic applications.

Modality
Ultrasound
Anatomy
Fetal, obstetric, abdominal, pelvic, pediatric, small-organ, cephalic, cardiac, vascular, musculoskeletal, lung, and urologic anatomy
Decision
2025-05-29
FDA-cleared K243378

Rapid MLS

iSchemaview Inc.

Authorized purpose: Brain midline-shift measurement on adult non-contrast CT

Modality
CT/CTA
Anatomy
Brain
Decision
2025-05-28
FDA-cleared K250367

CoLumboX

Smart Soft Healthcare AD

Authorized purpose: Post-processing segmentation, measurement, threshold labeling, and export of quantitative lumbar-spine measurements to support clinical review; not diagnosis.

Modality
X-ray/Radiography
Anatomy
Lumbar spine, including vertebrae and sacrum
Decision
2025-05-28
FDA-cleared K242594

DEEPECHO

DeepEcho

Authorized purpose: Detect standard fetal biometry views and assist fetal biometry measurements during prenatal ultrasound acquisition and interpretation.

Modality
Ultrasound
Anatomy
Fetal biometry views and structures: cephalic/head, abdomen, and femur
Decision
2025-05-23
FDA-cleared K242437

Smile Dx®

Cube Click, Inc.

Authorized purpose: Aids dentists reviewing bitewing and periapical radiographs of permanent teeth by detecting/segmenting caries and periapical radiolucencies, identifying restorations and dental anatomy, and measuring mesial/distal bone levels; it does not replace dentist review.

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2025-05-14
FDA-cleared K243230

Second Opinion® BLE

Pearl Inc.

Authorized purpose: Second Opinion BLE identifies and displays bone-level measurements in bitewing and periapical radiographs for dental health professionals reviewing permanent teeth in patients age 12 and older as a concurrent or second reader, not as a sole diagnosis.

Modality
X-ray/Radiography
Anatomy
Dental permanent teeth and alveolar bone
Decision
2025-05-09
FDA-cleared K250226

Clarius Median Nerve AI

Clarius Mobile Health Corp.

Authorized purpose: Segmentation and semi-automatic, non-invasive median-nerve cross-sectional-area measurement during ultrasound acquisition.

Modality
Ultrasound
Anatomy
Median nerve in the forearm and wrist
Decision
2025-05-08
FDA-cleared K250087

Vscan Air

GE Medical Systems Ultrasound and Primary Care Diagnostics

Authorized purpose: Vscan Air is a wireless handheld point-of-care ultrasound system for broad adult, pediatric, and neonatal applications. K250087 adds deep-learning automatic bladder-volume measurement and compatibility with separately cleared Caption Guidance and AutoEF functions.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-05-01
FDA-cleared K243651

VersaViewer

GE Medical Systems SCS

Authorized purpose: VersaViewer supports two-dimensional, three-dimensional, and four-dimensional medical-image series processing and analysis through customizable layouts, multimodality review, and measurements for trained healthcare professionals; it is not for displaying digital mammography for diagnosis.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Multi-region anatomy represented in CT, MR, PET, NM, XA, and other supported studies
Decision
2025-04-21
FDA-cleared K250416

GBrain MRI

Galileo CDS, Inc

Authorized purpose: Post-processing automatic segmentation, quantification, and reporting of brain FLAIR hyperintensity volumes to support structural MRI review; not disease detection or diagnosis.

Modality
MRI
Anatomy
Adult brain, specifically T2-weighted FLAIR hyperintensities
Decision
2025-04-11
FDA-cleared K243145

syngo.CT LVO Detection

Siemens Medical Solutions USA, Inc.

Authorized purpose: AI-assisted acute-care triage and notification of suspected large-vessel occlusion on contrast-enhanced head CTA to prioritize review; not diagnosis.

Modality
CT/CTA
Anatomy
Brain/head vasculature, specifically the ICA, M1, and M2 segments
Decision
2025-04-10
FDA-cleared K250754

cmAngio® (V1.6)

CureMetrix, Inc.

Authorized purpose: cmAngio (V1.6) processes screening mammograms to aid a qualified interpreting physician in the manual process of identifying breast arterial calcification. It detects the presence or absence of breast arterial calcifications at the study and breast level in full-field digital mammography and digital breast tomosynthesis screening mammograms and marks BAC segments on image thumbnails for localization.

Modality
Mammography/DBT
Anatomy
Female breasts; breast arterial calcification
Decision
2025-04-10
FDA-cleared K243769

QFR (3.0)

QFR Solutions bv

Authorized purpose: QFR (3.0) uses paired coronary X-ray angiographic DICOM acquisitions to calculate three-dimensional vessel and lesion measurements and pressure-drop quantification for interventional cardiologist or researcher review in patients with coronary artery disease.

Modality
Fluoroscopy/Angiography
Anatomy
Heart/Cardiovascular
Decision
2025-04-04
FDA-cleared K242551

syngo Dynamics (Version VA41D)

Siemens Healthcare GmbH

Authorized purpose: syngo Dynamics VA41D is a multimodality, vendor-agnostic cardiology image and information system for management, processing, review, post-processing, and quantification of cardiac ultrasound, X-ray angiography, nuclear medicine, CT, MR, vascular ultrasound, and obstetric or fetal studies.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Cardiac, vascular, obstetric, and fetal anatomy represented in multimodality studies
Decision
2025-04-03
FDA-cleared K241984

Hi-D Imaging 4TAVR

Hi-D Imaging AG

Authorized purpose: Pre-procedural cardiovascular anatomy assessment, measurement, visualization, sizing, and planning support for transcatheter aortic valve replacement.

Modality
CT/CTA
Anatomy
Heart and cardiovascular vessels, including the aortic valve/root, LVOT, annulus, aorta, ventricles, atria, myocardium, and pulmonary artery
Decision
2025-04-02
FDA-cleared K242166

TribusConnect

TribusMed Beheer BV

Authorized purpose: TribusConnect provides remote viewing and manipulation of CT DICOM data for pre- and post-cardiac-intervention review, including volume rendering, heart segmentation, simulated fluoroscopy, endoluminal views, MIP, and MPR; it is an adjunct and not diagnostic on mobile devices.

Modality
CT/CTA
Anatomy
Cardiac anatomy
Decision
2025-03-31
FDA-cleared K241961

Vent Creativity Knee v1.0 (Hermes)

Vent Creativity

Authorized purpose: Vent Creativity Knee v1.0 (Hermes) assists healthcare professionals in transferring CT imaging into bone segmentation and preoperative orthopedic planning outputs, including proximal tibial and distal or posterior femoral cut-plane planning and diagnostic physical replicas.

Modality
CT/CTA
Anatomy
Knee/femur/tibia/fibula/patella
Decision
2025-03-20
FDA-cleared K243292

brAIn™ Shoulder Positioning

Avatar Medical

Authorized purpose: brAIn Shoulder Positioning assists shoulder surgeons with preoperative planning and visualization for primary total shoulder replacement by segmenting shoulder CT data and allowing interactive implant positioning; it is an information tool and does not make the final surgical decision.

Modality
CT/CTA
Anatomy
Shoulder/scapula/humerus
Decision
2025-03-20
FDA-cleared K243689

AVIEW

Coreline Soft Co., Ltd.

Authorized purpose: AVIEW provides CT values for pulmonary tissue from thoracic and cardiac CT datasets. The FDA indication describes lung, lobe, airway, fissure, nodule, and cardiac analysis, including nodule measurements, Lung-RADS support, and coronary calcium scoring, for adult patients.

Modality
CT/CTA
Anatomy
Chest/lung and heart/coronary arteries
Decision
2025-03-19
FDA-cleared K250042

PeekMed web

Peek Health, S.A.

Authorized purpose: PeekMed web supports preoperative planning from imported patient imaging with two-dimensional and three-dimensional visualization, measurements, templates, and procedure planning; qualified professionals must revise and approve the output using clinical assessment.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Patient-specific surgical anatomy represented in imported medical imaging
Decision
2025-03-19
FDA-cleared K242338

Cleerly LABS (v2.0)

Cleerly, Inc.

Authorized purpose: Assists trained professionals with coronary-vessel, lumen, vessel-wall, plaque and stenosis visualization and measurements from CCTA; it does not replace clinical judgment.

Modality
CT/CTA
Anatomy
Heart/Coronary arteries
Decision
2025-03-07
FDA-cleared K243933

Ceevra Reveal 3+

Ceevra, Inc.

Authorized purpose: CT and MR 3D segmentation, measurements and interactive models for adult preoperative and intraoperative surgical planning; not primary diagnosis.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Multi-region
Decision
2025-03-04
FDA-cleared K241922

Myomics

Phantomics Inc.

Authorized purpose: Myomics assists qualified medical professionals with viewing, post-processing and qualitative/quantitative evaluation of 3T cardiovascular MR images in DICOM format, including heart and adjacent-vessel measurements; semi-automated machine-learning workflows are intended for adults and contribute to comprehensive diagnostic decision-making.

Modality
MRI
Anatomy
Heart/Cardiovascular
Decision
2025-02-28
FDA-cleared K241546

aiCockpit AI Viewer

Fovia, Inc.

Authorized purpose: aiCockpit AI Viewer displays DICOM and AI images with annotations, measurements, three-dimensional reformats, and reports for trained healthcare professionals; the physician retains the final clinical interpretation.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Multi-region anatomy represented in general-radiology and other healthcare imaging studies
Decision
2025-02-26
FDA-cleared K242240

CaRi-Plaque

Caristo Diagnostics Ltd.

Authorized purpose: CaRi-Plaque is a web-based post-processing tool for trained operators and healthcare professionals that analyzes previously acquired CCTA DICOM data for coronary plaque characteristics, plaque burden, luminal stenosis, and related vessel measurements.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2025-02-20
FDA-cleared K243294

Brainomix 360 e-ASPECTS

Brainomix Limited

Authorized purpose: Brainomix 360 e-ASPECTS registers adult non-contrast brain CT, segments ASPECTS regions, and provides an editable ASPECTS score with highlighted regions and voxel contribution views to assist trained clinicians evaluating suspected ischemic stroke within 24 hours of last known well.

Modality
CT/CTA
Anatomy
Brain
Decision
2025-02-14
FDA-cleared K243696

AVIEW CAC

Coreline Soft Co., Ltd.

Authorized purpose: Quantitative coronary-calcium analysis and risk stratification on existing non-contrast, non-gated chest CT studies.

Modality
CT/CTA
Anatomy
Heart and coronary arteries, specifically the right and left coronary arteries
Decision
2025-02-14
FDA-cleared K241659

Ultrasound Workspace (UWS 6.0)

Philips Ultrasound LLC

Authorized purpose: Ultrasound Workspace reviews, quantifies, and reports structures and function from multidimensional digital medical data from different modalities in cardiovascular, fetal, and abdominal workflows to support physician diagnosis.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Cardiovascular, fetal, and abdominal anatomy represented in multidimensional medical data
Decision
2025-02-10
FDA-cleared K241593

BoneMetrics (US)

Gleamer SAS

Authorized purpose: BoneMetrics is fully automated software that assists trained radiology professionals with Cobb-angle measurement on frontal spine radiographs in patients aged four years or older with suspected or present spinal deformity or scoliosis; it is not a replacement for complete evaluation or sole diagnosis.

Modality
X-ray/Radiography
Anatomy
Spine
Decision
2025-02-05
FDA-cleared K250035

Contour ProtégéAI+

MIM Software Inc.

Authorized purpose: Contour ProtégéAI+ automatically creates contours on CT and T2 MR DICOM images as an accessory to MIM software for quantitative analysis, adaptive therapy, transfer, and archive; users must review and edit contours, and the device is not intended to detect or contour lesions.

Modality
Radiotherapy Planning Imaging
Anatomy
CT anatomical regions; prostate, seminal vesicles, and urethra on T2 MR
Decision
2025-02-03
FDA-cleared K243229

Bunkerhill AVC

BunkerHill Health

Authorized purpose: Adjunctive opportunistic detection and quantification of aortic valve calcification during routine clinical-care chest CT review; a physician reviews the informational ROI and estimated calcium burden and decides any further action.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2025-01-27
FDA-cleared K243158

TeraRecon Aorta.CT (1.1.0)

TeraRecon, Inc.

Authorized purpose: TeraRecon Aorta.CT (1.1.0) automatically segments the aorta and labels 22 aortic anatomical landmarks from adult contrast CTA DICOM for trained professionals' review in standard-of-care planning; it does not alter the original images or provide a diagnosis and excludes the FDA-listed device/anatomy conditions.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2025-01-23
FDA-cleared K242825

Prenuvo Body Composition

Prenuvo

Authorized purpose: Prenuvo Body Composition is software that non-invasively quantifies fat, muscle, and organs from compatible MR DICOM datasets and displays internal body information, including liver and body-composition measurements, for adults age 18 and older.

Modality
MRI
Anatomy
Whole-body anatomy, liver, organs, fat, and muscle
Decision
2025-01-17
FDA-cleared K241696

Ortho AI

Ortho AI LLC

Authorized purpose: Ortho AI measures lengths, angles, and implant position relative to bone on radiographic images for total hip arthroplasty, total knee arthroplasty, and lumbar-spine fusion workflows, with editable overlays for adult orthopedic review; it is not primary interpretation or mobile use.

Modality
X-ray/Radiography
Anatomy
Pelvis, knee, and lumbar spine
Decision
2025-01-02
FDA-cleared K242270

OrthoNext Platform System

Orthofix Srl

Authorized purpose: The OrthoNext Platform System is indicated to assist healthcare professionals in preoperative planning of orthopedic surgery and postoperative planning of orthopedic treatment. It overlays Orthofix product templates on radiological images and provides tools for image measurement and template positioning.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Patient-specific orthopedic anatomy
Decision
2024-12-19
FDA-cleared K240793

MSKai

MSKai

Authorized purpose: Assist physicians in reviewing previously acquired lumbar-spine MRI by providing user-confirmed anatomy identification, segmentation, labeling, measurements, and reporting; it is not a diagnostic device.

Modality
MRI
Anatomy
Lumbar spine, including vertebral bodies L1-S1, intervertebral discs, cord canal, dural sac, nerve roots, and posterior arch.
Decision
2024-12-16
FDA-cleared K242461

IRISeg

Intuitive Surgical Inc.

Authorized purpose: IRISeg receives DICOM-compliant contrast-enhanced CT images, provides manual and machine-learning-enabled image-analysis and segmentation tools, and creates an output file for a three-dimensional model used in preoperative planning and intraoperative display. The kidney CT auto-segmentation tool is indicated for adult patients with contrast-enhanced axial kidney CT images with slice thickness of 3 mm or less.

Modality
CT/CTA
Anatomy
Kidneys
Decision
2024-12-10
FDA-cleared K240680

CDM Insights

Oxford Brain Diagnostics Ltd

Authorized purpose: Assist trained healthcare practitioners in viewing, analyzing, quantifying, and evaluating MR brain images of adults older than 45 years, including segmentation, normative comparison, and reporting.

Modality
MRI
Anatomy
Brain, including individual brain structures, cortical regions, and white matter hyperintensities.
Decision
2024-12-06
FDA-cleared K240926

PeekMed web

Peek Health, S.A.

Authorized purpose: PeekMed web is designed to help healthcare professionals perform preoperative planning for surgical procedures using imported patient imaging studies. The FDA material describes two-dimensional and three-dimensional image representation, measurements, templates, and a database of digital representations of surgical materials supplied by manufacturers.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Patient-specific anatomy for surgical planning
Decision
2024-12-06
FDA-cleared K242203

BriefCase-Quantification

Aidoc Medical, Ltd.

Authorized purpose: Analyzes contrast-enhanced CT exams including the aorta to measure normal or aneurysmal aortas.

Modality
CT/CTA
Anatomy
Aorta
Decision
2024-11-22
FDA-cleared K242359

Strain AI (SAI001)

Exo Inc

Authorized purpose: Measures global longitudinal strain from apical four-chamber cardiac ultrasound images in adult patients with suspected disease as an aid to diagnostic analysis; users can accept or reject measurements.

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2024-11-20
FDA-cleared K242130

Koios DS

Koios Medical, Inc.

Authorized purpose: Koios Decision Support (DS) is an artificial intelligence (AI)/machine learning (ML)-based computer-aided diagnosis (CADx) software device intended for use as an adjunct to diagnostic ultrasound examinations of lesions or nodules suspicious for breast or thyroid cancer. Koios DS allows the user to select or confirm regions of interest (ROIs) within an image representing a single lesion or nodule to be analyzed. The software then automatically characterizes the selected image data to generate an AI/MLderived cancer risk assessment and selects applicable lexicon-based descriptors designed to improve overall diagnostic accuracy as well as reduce interpreting physician variability. Koios DS software may also be used as an image viewer of multi-modality digital images, including ultrasound and mammography. The software includes tools that allow users to adjust, measure and document images, and output into a structured report. Koios DS software is designed to assist trained interpreting physicians in analyzing the breast ultrasound images of adult (>= 22 years) female patients with soft tissue breast lesions and/or thyroid ultrasounds of all adult (>= 22 years) patients with thyroid nodules suspicious for cancer. When utilized by an interpreting physician who has completed the prescribed training, this device provides information that may be useful in recommending appropriate clinical management.

Modality
Ultrasound
Anatomy
Breast
Decision
2024-11-15
FDA-cleared K241312

TeraRecon Cardiac.Chambers.MR (1.0.0)

TeraRecon,Inc.

Authorized purpose: Provide cardiac-chamber segmentations for trained healthcare professionals reviewing adult cardiac MR to assist diagnosis or treatment planning; the physician makes final patient-management decisions.

Modality
MRI
Anatomy
Cardiac chambers: left-ventricular myocardium and chamber, and right-ventricular chamber for the Cine-ax component; left-ventricular myocardium and chamber for the De-ax component.
Decision
2024-11-05
FDA-cleared K242215

Neurophet AQUA (V3.1)

Neurophet, Inc.

Authorized purpose: Neurophet AQUA is intended for Automatic labeling, visualization and volumetric quantification of segmentable brain structures and lesions from a set of MR images. Volumetric data may be compared to reference percentile data.

Modality
MRI
Anatomy
Brain
Decision
2024-10-25
FDA-cleared K243189

TumorSight Viz

SimBioSys, Inc.

Authorized purpose: Visualize and analyze DCE breast MRI studies for patients with biopsy-proven early-stage or locally advanced breast cancer, including processing, measurements, and configurable finding visualization; results are not a sole basis for patient management.

Modality
MRI
Anatomy
Breast, including biopsy-proven breast tumors/findings.
Decision
2024-10-25
FDA-cleared K242781

cvi42 Software Application

Circle Cardiovascular Imaging Inc.

Authorized purpose: View, post-process, and qualitatively and quantitatively evaluate cardiovascular MR and CT images in DICOM format to obtain diagnostic information as part of a comprehensive diagnostic decision-making process.

Modality
CT/CTA; MRI
Anatomy
Cardiovascular system; heart, coronary and adjacent vessels, and cardiac valves
Decision
2024-10-15
FDA-cleared K241430

EchoMeasure

iCardio.ai

Authorized purpose: Process previously acquired DICOM-compliant cardiac ultrasound images and make automated cardiac measurements to support qualified cardiologists, sonographers, or other licensed healthcare practitioners in adult clinical decision-making.

Modality
Ultrasound
Anatomy
Heart and cardiovascular structures
Decision
2024-10-10
FDA-cleared K241029

SpineUs™ System

Verdure Imaging

Authorized purpose: Tracked B-mode ultrasound acquisition, display, and scoliosis-angle measurement of the spine for trained users as an adjunct to conventional imaging; it is not the sole basis for patient management.

Modality
Ultrasound
Anatomy
Spine
Decision
2024-10-07
FDA-cleared K240553

LVivo Software Application

DiA Imaging Analysis Ltd.

Non-invasive processing of ultrasound images to detect, measure, and calculate relevant medical parameters of structures and function in patients with suspected disease, with Quality Score feedback.

Modality
Ultrasound
Anatomy
Heart and cardiovascular structures, especially the left and right ventricles; a bladder-volume module is also described
Decision
2024-10-04
FDA-cleared K242005

Versana Premier; Versana Premier Lotus; LOGIQ F

GE Medical Systems Ultrasound and Primary Care Diagnostics

Authorized purpose: Versana Premier, Versana Premier Lotus, and LOGIQ F are general-purpose diagnostic ultrasound systems for broad hospital and clinic applications; K242005 adds transesophageal use, reporting and guidance tools, measurements, remote service functions, and other release-specific workflow features.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2024-10-02
FDA-cleared K240943

LungVision

BodyVision Medical Ltd.

Authorized purpose: The LungVision System enables users to segment previously acquired 3D CT datasets and overlay and register those segmented datasets with fluoroscopic live X-ray images of the same anatomy to support catheter or device navigation during pulmonary procedures.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Lungs; bronchial airways; pulmonary procedures
Decision
2024-10-01
FDA-cleared K241331

MuscleView

Springbok, Inc.

Authorized purpose: Automatically segment lower-extremity muscle and bone structures from MRI in patients aged 18 years and older and provide derived muscle volume, bone volume, intramuscular fat percentage, and left/right asymmetry metrics; the output is not direct disease diagnosis.

Modality
MRI
Anatomy
Lower extremities; 72 muscles and 8 bones including pelvis, femur, tibia, and fibula, bilaterally
Decision
2024-10-01
FDA-cleared K240369

CAC (gated) Algorithm

BunkerHill Health

Authorized purpose: Estimate the presence and quantity of coronary artery calcium in patients aged 30 years and older from non-contrast ECG-gated chest CT, with informational segmentation and quantification available to a physician for adjunctive review.

Modality
CT/CTA
Anatomy
Coronary arteries and coronary artery calcium within the heart
Decision
2024-09-27
FDA-cleared K240036

PIUR tUS Infinity

PIUR Imaging GmbH

Authorized purpose: PIUR tUS Infinity supports a computer-aided thyroid ultrasound workflow that identifies thyroid lobes and margins, calculates volume, marks and quantifies nodules, and provides user-selected ACR TI-RADS parameters subject to user review and confirmation.

Modality
Ultrasound
Anatomy
Thyroid
Decision
2024-09-20
FDA-cleared K241280

Constellation (CON-001)

Q Bio, Inc.

Authorized purpose: Constellation is intended for non-invasive labeling and calculation of quantitative measurements for anatomical regions using whole-body DICOM MR images gathered on a GE MR450W. It is intended for healthy adult patients and may be used as a clinical decision-support tool, but not in triage events, emergency medicine, or critical care; a clinician retains responsibility for diagnosis.

Modality
MRI
Anatomy
Whole body including lower-limb muscles, visceral and subcutaneous adipose tissue, kidneys, liver, spleen, lungs, and brain structures
Decision
2024-09-12
FDA-cleared K240791

ADAS 3D

Adas3D Medical S.L

Authorized purpose: ADAS 3D provides visualization, analysis, and quantification of MR and CT heart images in individual patients with cardiovascular disease, including myocardial scar assessment for pre-planning and during electrophysiology procedures.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Heart; myocardial scar and cardiovascular structures
Decision
2024-09-09
FDA-cleared K233998

TRAQinform IQ

AIQ Global, Inc.

Authorized purpose: Quantitative single-timepoint or longitudinal analysis of lesion ROIs on adult PET/CT, including volume, density, and tracer-uptake changes, with a report used as an adjunct to local image interpretation.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body and lesion regions of interest
Decision
2024-09-05
FDA-cleared K233977

Velacur

Sonic Incytes

Authorized purpose: Velacur Sonic measures liver tissue stiffness, ultrasound attenuation, and volume density fat fraction with shear-wave and ultrasound measurements to aid clinical management of liver disease, including steatosis, within the labeled workflow.

Modality
Ultrasound
Anatomy
Liver
Decision
2024-09-04
FDA-cleared K241585

uMI Panorama

Shanghai United Imaging Healthcare Co.,Ltd.

Authorized purpose: uMI Panorama GS combines 148 cm axial-field-of-view PET with CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and registered or fused PET/CT images supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation. K241585 adds reconstruction, respiratory-motion, CT-less attenuation-correction, quantitative-normalization, quality-control, and AI-expanded-field-of-view functions.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2024-08-30
FDA-cleared K241847

Imbio PHA (4.0.0)

Imbio, Inc

The Imbio PHA Software device is designed to measure the maximal diameters of the right and left ventricles of the heart, the main pulmonary artery, and the ascending aorta from a volumetric CTPA acquisition and report the RV/LV and Pa/Ao ratios. PHA analyzes cases using an artificial intelligence algorithm to identify the location and measurements of the anatomy. The PHA software provides the user with annotated images showing measurements. Its results are not intended to be used on a stand-alone basis for clinical decision-making or otherwise preclude clinical assessment of CTPA cases.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2024-08-30
FDA-cleared K242275

syngo.via MI Workflows; Scenium; syngo MBF

Siemens Medical Solutions USA, Inc.

Authorized purpose: syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2024-08-30
FDA-cleared K242300

MI View&GO

Siemens Medical Solutions USA, Inc.

Authorized purpose: MI View&GO is a medical diagnostic application for viewing, manipulating, quantifying, analyzing, and comparing PET, nuclear-medicine, CT, and MR images. The FDA material describes use across labeled oncology, cardiology, neurology, organ-function, and radiotherapy-planning workflows.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Multi-region PET, nuclear-medicine, CT, and MR studies
Decision
2024-08-30
FDA-cleared K233826

Kosmos

EchoNous, Inc.

Kosmos acquires, processes, displays, measures, and stores ultrasound with synchronized ECG and digital auscultation across cardiac, lung, abdominal, vascular, musculoskeletal, and interventional applications. Adult-only Auto EF and AI FAST are adjunct functions.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2024-08-29
FDA-cleared K241098

NeuroQuant

CorTechs Labs, Inc.

Authorized purpose: NeuroQuant automatically labels, visualizes, and volumetrically quantifies segmentable brain structures and lesions from MR images, optionally using T2 FLAIR and T2* GRE/SWI for lesion analysis; outputs require radiologist/neuroradiologist review and may be compared with reference percentiles.

Modality
MRI
Anatomy
Brain
Decision
2024-08-22
FDA-cleared K241211

CoLumbo

Smart Soft Healthcare

Authorized purpose: CoLumbo version 3 is an image post-processing and measurement tool that provides quantitative measurements of the lumbar spine from previously acquired lumbar-spine MR images.

Modality
MRI
Anatomy
Lumbar spine
Decision
2024-08-15
FDA-cleared K233822

i2Contour

MRIMath LLC

Authorized purpose: Semi-automatic segmentation, labeling, and volumetric quantification of known WHO grade 4 glioblastoma in adults aged 18 years or older using T1 post-contrast or FLAIR MRI.

Modality
MRI
Anatomy
Brain and glioblastoma
Decision
2024-08-08
FDA-cleared K233731

CardIQ Suite

GE Medical Systems SCS

Authorized purpose: Cardiac CT visualization, measurement, segmentation, tracking, labeling, and calcium scoring to support review of cardiovascular anatomy and pathology, coronary artery disease, and treatment-path decisions.

Modality
CT/CTA
Anatomy
Heart and cardiovascular structures, including coronaries, chambers, vessels, valves, and aorta
Decision
2024-08-01
FDA-cleared K234141

AISAP Cardio V1.0

Aisap

Authorized purpose: AISAP CARDIO V1.0 automatically processes and analyzes acquired cardiac POCUS images and produces a report with diagnostic assessment and measurements, including selected valvular pathology, LVEF, ventricular dimensions, RV FAC, atrial areas, ascending-aorta diameter, and IVC diameter, to support qualified physicians using FDA-cleared ultrasound devices.

Modality
Ultrasound
Anatomy
Heart/cardiovascular structures
Decision
2024-08-01
FDA-cleared K233457

RUS

Hutom Inc.

Authorized purpose: RUS processes CT images for trained professionals using organ and vessel segmentation, pneumoperitoneum estimation, measurements, paths, and two- or three-dimensional visualization to support reporting and treatment or surgical planning.

Modality
CT/CTA
Anatomy
Chest/Abdomen
Decision
2024-07-12
FDA-cleared K234009

Acorn 3D Software (AC-SEG-4009); Acorn 3DP Model (AC-101-XX)

Mighty Oak Medical

Authorized purpose: Acorn Segmentation is intended as an image-segmentation interface for transferring CT or CTA images to an output file, measuring, and treatment planning. The output can be used to fabricate Acorn 3DP Models by additive manufacturing for diagnostic musculoskeletal and craniomaxillofacial applications.

Modality
CT/CTA
Anatomy
Musculoskeletal and craniomaxillofacial anatomy
Decision
2024-07-12
FDA-cleared K240736

SMART Bun-Yo-Matic X-Ray

Disior Ltd

Foot and ankle radiograph analysis for orthopaedic visualization, measurements, and preoperative surgical planning by qualified professionals.

Modality
X-ray/Radiography
Anatomy
Foot/Ankle
Decision
2024-07-02
FDA-cleared K240582

VEA Align; spineEOS

EOS imaging

Authorized purpose: VEA Align uses 2D X-ray images acquired in EOS imaging systems to display interactive landmarks and support global-alignment assessment, angle and length measurements, and analysis of spinal deformities, degenerative diseases, and lower-limb alignment disorders in pediatric and adult patients aged 7 years and older. spineEOS assists healthcare professionals with preoperative spine-surgery planning using EOS images, 3D datasets, measurements, and patient-specific surgical-strategy tools.

Modality
X-ray/Radiography
Anatomy
Spine and lower limbs; global alignment and deformity
Decision
2024-06-25
FDA-cleared K233196

Medihub Prostate

JLK Inc.

Authorized purpose: Assist trained radiologists and urologists in reviewing and analyzing prostate MR studies through semi-automatic prostate outlining, multiparametric visualization, and related measurements and reporting; patient-management decisions must not rely on the software alone.

Modality
MRI
Anatomy
Prostate
Decision
2024-06-21
FDA-cleared K240642

SMART Bun-Yo-Matic CT

Disior Ltd

Authorized purpose: Foot and ankle CT analysis for three-dimensional visualization, measurements, and preoperative surgical planning by qualified orthopaedic professionals.

Modality
CT/CTA
Anatomy
Foot/Ankle
Decision
2024-06-20
FDA-cleared K233955

Clarius OB AI

Clarius Mobile Health Corp.

Authorized purpose: Clarius OB AI assists a trained and qualified healthcare professional with measurements of fetal biometric parameters, including head circumference, abdominal circumference, femur length, biparietal diameter, and crown-rump length, on data acquired by the Clarius curvilinear ultrasound scanner.

Modality
Ultrasound
Anatomy
Fetal anatomy and fetal biometric landmarks
Decision
2024-06-14
FDA-cleared K241083

SIS System

Surgical Information Sciences, Inc.

Authorized purpose: SIS System fuses clinical brain MRI with postoperative CT to visualize DBS anatomy, localize STN, GPe, GPi, and Vim, and segment implanted leads for surgical review.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Brain
Decision
2024-06-14
FDA-cleared K233209

uOmnispace.CT

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uOmnispace.CT is software for viewing, manipulating, evaluating, and analyzing medical images within healthcare institutions. The FDA indication lists colon visualization, dental panoramic and paraxial reconstruction, lung and airway segmentation and quantitative parameters, nodule analysis, vessel and brain-perfusion analysis, heart and coronary analysis, calcium scoring, dynamic analysis, bone-structure labeling, liver evaluation, dual-energy processing, and cardiovascular combined analysis.

Modality
CT/CTA
Anatomy
Colon, jaw, lungs, airways, brain, heart, vessels, liver, spine, ribs, and other labeled CT regions
Decision
2024-05-17
FDA-cleared K241112

BriefCase-Quantification

Aidoc Medical, Ltd.

Authorized purpose: Analyzes contrast CT exams containing the abdominal aorta and provides maximum abdominal-aortic diameter measurement.

Modality
CT/CTA
Anatomy
Abdominal aorta
Decision
2024-05-15
FDA-cleared K232928

DeepContour (V1.0)

Wisdom Technologies., Inc.

Authorized purpose: DeepContour uses deep-learning CT processing to generate editable organ contours and RTSTRUCT objects for selected adult radiation-treatment planning workflows, with quantitative statistics, registration, and three-dimensional visualization; it does not contour tumors.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2024-05-07
FDA-cleared K233698

True Enhance DL

GE Healthcare Japan Corporation

Improve contrast of 120 kVp single-energy body CT images by estimating 50 keV GSI-like images as non-quantitative adjunct information for patients of all ages; the original 120 kVp image must remain available for interpretation.

Modality
CT/CTA
Anatomy
Body
Decision
2024-04-11
FDA-cleared K233676

Us2.v2

Eko.ai Pte. Ltd d/b/a Us2.ai

Authorized purpose: Us2.v2 processes acquired transthoracic cardiac ultrasound images to provide automated estimates and measurements of atrial and ventricular dimensions, volumes, and systolic and diastolic function.

Modality
Ultrasound
Anatomy
Adult heart; atrial and ventricular structures and function
Decision
2024-04-01
FDA-cleared K233211

AVIEW CAC

Coreline Soft Co., Ltd.

Authorized purpose: Provides quantitative coronary-plaque analysis using Agatston scoring, RCA/LCA segmentation, and calcium-score, gender, and age percentile risk stratification.

Modality
CT/CTA
Anatomy
Heart and coronary arteries
Decision
2024-03-29
FDA-cleared K233753

AI-Rad Companion (Pulmonary)

Siemens Healthcare GmbH

Authorized purpose: AI-Rad Companion Pulmonary is image-processing software that provides quantitative and qualitative analysis from previously acquired CT DICOM images to support radiologists and physicians in evaluating and assessing lung disease. It segments and measures lungs, lobes, parenchyma, and solid or sub-solid nodules, identifies areas above or below specified Hounsfield-value thresholds, supports an external Lung CAD interface, associates nodules with lobes, and compares current nodules with known priors. Valid input is DICOM imaging of adult patients; the FDA summary identifies software version VA40.

Modality
CT/CTA
Anatomy
Adult lungs, lung lobes, pulmonary parenchyma, and solid or sub-solid lung nodules
Decision
2024-03-21
FDA-cleared K233968

CINA-iPE

Avicenna.AI

Authorized purpose: Worklist triage and notification for suspected incidental pulmonary embolism on contrast-enhanced CT acquired for another indication; not a diagnostic device

Modality
CT/CTA
Anatomy
Lung and pulmonary arterial segments containing incidental pulmonary embolism; subsegmental arteries are out of scope
Decision
2024-03-13
FDA-cleared K231677

EdgeFlow UH10

Edgecare Inc.

Authorized purpose: EdgeFlow UH10 is an ultrasound device intended to measure urine volume in the bladder noninvasively in professional healthcare facilities such as hospitals and clinics by qualified and trained healthcare professionals. The FDA indication describes B-mode and harmonic imaging modes.

Modality
Ultrasound
Anatomy
Urinary bladder
Decision
2024-03-06
FDA-cleared K233738

Overjet Caries Assist-Pediatric

Overjet, Inc

Authorized purpose: Aid dentists in detecting and segmenting caries on bitewing and periapical radiographs for patients aged 4-11 with primary or permanent teeth; the output is additional information and does not replace a complete dental review or clinical judgment.

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial (carious tooth surfaces)
Decision
2024-03-04
FDA-cleared K233080

HealthFLD

Nano-X AI Ltd.

Authorized purpose: Provide quantitative and qualitative liver analysis and mean attenuation measurement to support clinician evaluation and assessment of fatty liver in patients aged 18-75 whose CT includes a significant part of the liver; not for diagnosis or risk assessment of fatty liver disease.

Modality
CT/CTA
Anatomy
Liver
Decision
2024-02-08
FDA-cleared K232363

Viz HDS, Viz Volume Plus, Viz ICH+

Viz.ai, Inc.

Authorized purpose: Automatically label, visualize, and quantify segmentable brain structures on single-time-point non-contrast head CT, including intracranial hyperdensities, lateral ventricles, and midline shift; output must be reviewed with the original images by a physician.

Modality
CT/CTA
Anatomy
Brain (intracranial hyperdensities, lateral ventricles, and midline shift)
Decision
2024-02-05
FDA-cleared K232698

NemoScan

Software Nemotec S.L.

NemoScan supports dental CT or cone-beam CT visualization, segmentation, implant and surgical planning, instrument positioning, and guide planning from preoperative maxillofacial images.

Modality
CBCT
Anatomy
Dental/Maxillofacial
Decision
2024-01-18
FDA-cleared K233512

Rapid (6.0)

iSchemaView, Inc.

Authorized purpose: Rapid Platform v6.0 is image-processing software for trained professionals that views, processes, and analyzes DICOM images from CT and MRI. It supports functional and dynamic datasets including CT perfusion, CT angiography, diffusion-weighted MRI, and dynamic contrast-enhanced CT or MRI, with maps and measurements for tissue perfusion, diffusion, and blood volume. Rapid CT-Perfusion and Rapid MR-Perfusion may aid physicians in selecting acute stroke patients with known occlusion of the intracranial internal carotid artery or proximal middle cerebral artery for endovascular thrombectomy, subject to the labeled imaging criteria, clinical requirements, and exclusions.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Brain and intracranial vessels represented in CT perfusion, CTA, and MRI; tissue perfusion, diffusion, and contrast dynamics
Decision
2024-01-16
FDA-cleared K231324

DASI Dimensions (V1.0)

DASI Simulations

Authorized purpose: Provide predefined cardiovascular images and measurements to support pre-procedural planning for patients with aortic stenosis being considered for TAVR; cardiologists and radiologists must interpret and validate the report and make all treatment decisions.

Modality
CT/CTA
Anatomy
Cardiovascular structures (aortic root, aortic valve, sinus of Valsalva, sinotubular junction, and ascending aorta)
Decision
2024-01-08
FDA-cleared K232412

LungQ v3.0.0

Thirona BV

The Thirona LungQ software provides reproducible CT values for pulmonary tissue which is essential for providing quantitative support for diagnosis and follow up examination. The LungQ software can be used to support physician in the diagnosis and documentation of pulmonary tissues images (e.g. abnormalities) from CT thoracic datasets. Three-D segmentation and isolation of sub-compartments, volumetric analysis, density evaluations, fissure evaluation, and reporting tools are provided.

Modality
CT/CTA
Anatomy
Chest/Lung
Decision
2024-01-08
FDA-cleared K231917

VEA Align

EOS imaging

Authorized purpose: VEA Align is cloud-based orthopedic software that uses 2D frontal and lateral X-ray images acquired in EOS imaging systems to display interactive landmarks and support patient-specific global-alignment assessment, angle and length measurements, and analysis of spinal deformities, degenerative disease, lower-limb alignment disorders, and deformities in adults and children age 7 years and older.

Modality
X-ray/Radiography
Anatomy
Spine and lower-limb alignment anatomy
Decision
2024-01-05
FDA-cleared K231130

TumorSight Viz

SimBioSys, Inc.

Authorized purpose: TumorSight Viz analyzes dynamic contrast-enhanced breast MRI for visualization and analysis of biopsy-proven early-stage or locally advanced breast cancer, including registration, subtraction, measurements, and three-dimensional views to support physician review.

Modality
MRI
Anatomy
Breast; early-stage or locally advanced breast cancer
Decision
2023-12-26
FDA-cleared K233176

uOmnispace.MI

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uOmnispace.MI is software for viewing, processing, evaluating, and analyzing PET, CT, MR, and SPECT images within healthcare institutions, with labeled applications for multimodality reporting, follow-up registration and lesion segmentation, dynamic PET analysis and time-activity curves, brain PET relative-activity analysis, and cardiac short-axis, perfusion, activity, and function analysis.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Multi-region PET, CT, MR, and SPECT examinations including oncology, neurology, cardiology, brain, and cardiac analyses
Decision
2023-12-20
FDA-cleared K231929

iQ-solutions

Sydney Neuroimaging Analysis Centre Pty Ltd

Authorized purpose: Automatically annotate, visualize, and quantify segmentable brain structures from brain MRI at one time point or longitudinally; longitudinal analysis is limited to the same patient's scans from the same scanner with consistent protocol and contrast at two time points.

Modality
MRI
Anatomy
Brain
Decision
2023-12-18
FDA-cleared K231570

StrokeViewer Perfusion

NICo-Lab B.V.

Authorized purpose: Provide quantitative perfusion information in brain tissue for suspected ischemic stroke patients using dynamic brain CT perfusion studies; medical imaging professionals use the information as additional data in the standard-of-care assessment, not as a standalone diagnostic tool.

Modality
CT/CTA
Anatomy
Brain
Decision
2023-12-14
FDA-cleared K232231

QP-Brain®

Quibim S.L.

Authorized purpose: Automatically label and volumetrically quantify segmentable brain structures and white matter hyperintensities (WMH) from MR images in adults and adolescents aged 18 years and older, as a support tool for properly trained clinicians assessing structural MRIs; patient-management decisions must not rely solely on the device results.

Modality
MRI
Anatomy
Brain
Decision
2023-12-13
FDA-cleared K223757

Bonelogic

Disior Ltd

Authorized purpose: Bonelogic 2.2 assists orthopedic healthcare professionals with diagnosis and surgical planning by semi-automatically segmenting bony structures from CT and producing foot and ankle 3D models and measurements for clinician review.

Modality
CT/CTA
Anatomy
Foot/ankle
Decision
2023-12-08
FDA-cleared K232381

LOGIQ Totus

GE Medical Systems Ultrasound and Primary care Diagnostics

Authorized purpose: LOGIQ Totus is a general-purpose diagnostic ultrasound system for trained healthcare professionals to image, measure, display, and analyze the human body and fluid across the labeled fetal, abdominal, pediatric, small-organ, cephalic, cardiac, vascular, musculoskeletal, urologic, transrectal, and transvaginal applications.

Modality
Ultrasound
Anatomy
Fetal/obstetric, abdominal, renal, gynecologic/pelvic, pediatric, breast, testes, thyroid, neonatal and adult cephalic, cardiac, vascular, musculoskeletal, urologic, transrectal, and transvaginal anatomy
Decision
2023-12-07
FDA-cleared K232661

Myocardial Strain Software Application

Circle Cardiovascular Imaging

Authorized purpose: Myocardial Strain Software Application provides qualitative and quantitative evaluation of cardiovascular MR images, including two-dimensional displacement, velocity, strain, strain rate, time to peak, and torsion after a qualified user confirms the contours.

Modality
MRI
Anatomy
Heart; left ventricular myocardium and cardiovascular structures
Decision
2023-12-07
FDA-cleared K233568

Ceevra Reveal 3+

Ceevra, Inc.

Authorized purpose: Process, review, analyze, communicate, and exchange multidimensional CT or MR images, including preliminary segmentation of normal anatomy, for preoperative surgical planning and intraoperative display; healthcare professionals make all final patient-management decisions. Machine-learning algorithms are for adults aged 22 years and older, while images for patients under 22 or of unknown age are generated without machine learning.

Modality
CT/CTA; MRI
Anatomy
Multi-region normal anatomy represented in CT or MR images; validated examples include prostate, bladder, neurovascular bundles, kidney, artery, and vein
Decision
2023-12-05
FDA-cleared K232856

Syngo Carbon Clinicals

Siemens Healthcare GmbH

Authorized purpose: Syngo Carbon Clinicals provides advanced visualization tools to prepare and process medical images acquired by modalities such as CT and MR for evaluation, manipulation, communication, qualitative and quantitative measurements, and analysis, with an interface to interconnected image-viewing, communication, and storage software.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Anatomy represented in CT, MR, and other supported clinical images, including lung lesion workflows
Decision
2023-12-01
FDA-cleared K232000

syngo.via MI Workflows; Scenium; syngo MBF

Siemens Medical Solutions USA, Inc.

Authorized purpose: syngo.via MI Workflows VB80A, Scenium VE60, and syngo MBF VB30 support PET, SPECT, nuclear-medicine, CT, and MR viewing, quantification, analysis, longitudinal comparison, organ segmentation, tumor-burden assessment, tau analysis, myocardial blood-flow analysis, and selected radiotherapy-planning support.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2023-11-28
FDA-cleared K232841

Axial3D Insight

Axial Medical Printing Limited

Authorized purpose: Axial3D Insight is a cloud-based service and image-segmentation framework that transfers DICOM imaging information from a medical scanner to an output file for additive-manufactured physical replicas, treatment planning, or diagnostic use in the labeled trauma, orthopedic, maxillofacial, and cardiovascular fields.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Patient-specific anatomy in trauma, orthopedic, maxillofacial, and cardiovascular applications
Decision
2023-11-15
FDA-cleared K232083

BriefCase-Quantification

Aidoc Medical, Ltd.

Authorized purpose: Automatic measurement of brain midline shift on non-contrast head CT in adults or transitional adolescents aged 18 years and older, including single-time-point measurement and same-patient multi-time-point comparison; not diagnostic.

Modality
CT/CTA
Anatomy
Brain, specifically midline shift
Decision
2023-11-13
FDA-cleared K232257

Clarius Bladder AI

Clarius Mobile Health Corp.

Authorized purpose: Provide semi-automatic, non-invasive bladder-volume measurements from ultrasound data acquired by the Clarius Ultrasound Scanner using curvilinear or phased-array scanners; a healthcare professional trained and qualified in ultrasound retains responsibility for the measurements, and the device is indicated for adults only.

Modality
Ultrasound
Anatomy
Bladder
Decision
2023-11-13
FDA-cleared K231765

Contour ProtégéAI

MIM Software Inc.

Authorized purpose: Contour ProtegeAI assists trained medical professionals with automated processing of CT and MR images, creates machine-learning contours for quantitative analysis, adaptive therapy, transfer to radiation-treatment planning systems, and archiving, segments structures across CT locations, and segments the prostate, seminal vesicles, and urethra on T2-weighted MR images.

Modality
Radiotherapy Planning Imaging
Anatomy
CT anatomic locations and the prostate, seminal vesicles, and urethra on T2-weighted MR
Decision
2023-11-08
FDA-cleared K231966

LOGIQ E10

GE Medical Systems Ultrasound and Primary care Diagnostics

Authorized purpose: LOGIQ E10 is a general-purpose diagnostic ultrasound system for broad adult and pediatric applications; K231966 adds AI-assisted renal measurements, anatomy-based preset and color suggestions, cardiac analysis, raw-data streaming, and Vscan Air CL support.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2023-11-07
FDA-cleared K231989

LOGIQ E10s, LOGIQ Fortis

GE Medical Systems Ultrasound and Primary Care Diagnostic

Authorized purpose: LOGIQ E10s and LOGIQ Fortis are general-purpose diagnostic ultrasound systems for trained healthcare professionals to image, measure, display, and analyze the human body and fluid across the labeled fetal, abdominal, pediatric, small-organ, cephalic, cardiac, vascular, musculoskeletal, urologic, transrectal, transvaginal, transesophageal, and intraoperative applications in hospitals or medical clinics.

Modality
Ultrasound
Anatomy
Fetal/obstetric, abdominal, gynecologic/pelvic, pediatric, breast, testes, thyroid, cephalic, cardiac, vascular, musculoskeletal, urologic, transrectal, transvaginal, transesophageal, and intraoperative anatomy
Decision
2023-11-07
FDA-cleared K231955

aprevo® Digital Segmentation

Carlsmed, Inc.

Authorized purpose: aprevo Digital Segmentation is software for trained, medically knowledgeable design personnel to perform digital image segmentation of the spine, primarily lumbar anatomy; it inputs DICOM images and outputs a three-dimensional spine model.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Spine, primarily lumbar anatomy
Decision
2023-11-03
FDA-cleared K232145

ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System

Siemens Medical Solutions USA, Inc.

Authorized purpose: The ACUSON Sequoia and Sequoia Select systems provide ultrasound images or signals for the labeled fetal, abdominal, pediatric, neonatal cephalic, small-parts, OB/GYN, cardiac, pelvic, vascular, adult-cephalic, musculoskeletal, and peripheral-vascular applications; the system also supports UDFF liver-fat-fraction measurement and the ACUSON Origin includes intracardiac and intraluminal imaging guidance during adult and pediatric cardiac procedures.

Modality
Ultrasound
Anatomy
Fetal, abdominal, pediatric, neonatal cephalic, small parts, OB/GYN, cardiac, pelvic, vascular, adult cephalic, musculoskeletal, peripheral vascular, intracardiac, and intraluminal cardiac or great-vessel anatomy
Decision
2023-10-30
FDA-cleared K232045

MeVis Liver Suite

MeVis Medical Solutions AG

Authorized purpose: CT and MRI image analysis, segmentation, visualization, and volumetry for adult abdominal treatment planning and follow-up, including liver surgery, living-donor, transplant, and oncologic workflows; it is not a diagnostic viewer or PACS replacement.

Modality
CT/CTA
Anatomy
Liver
Decision
2023-10-27
FDA-cleared K232305

AI-Rad Companion Brain MR

Siemens Medical Solutions U.S.A.

Authorized purpose: Post-processing image analysis to assist clinicians in viewing, analyzing, and evaluating MR brain images through automated segmentation, quantitative analysis, normative comparison, and report presentation.

Modality
MRI
Anatomy
Brain structures and white matter hyperintensities
Decision
2023-10-23
FDA-cleared K230209

Sonix Health

Ontact Health Co., Ltd.

Authorized purpose: Sonix Health quantifies and reports adult echocardiography by or on the order of a licensed physician using B-mode, M-mode, pulsed-wave Doppler, and continuous-wave Doppler images.

Modality
Ultrasound
Anatomy
Heart; adult cardiac structures and function
Decision
2023-10-20
FDA-cleared K231642

Veuron-Brain-pAb3

Heuron Co., Ltd.

Authorized purpose: Registration, fusion, display, and quantitative SUVR analysis of brain amyloid PET with MRI support to aid clinician assessment; outputs are reference information, not a stand-alone dementia diagnosis.

Modality
MRI
Anatomy
Brain
Decision
2023-10-13
FDA-cleared K232367

cmAngio® V1.0

CureMetrix, Inc.

Authorized purpose: cmAngio processes screening FFDM and DBT mammograms to detect presence or absence of breast arterial calcifications at study and breast level and mark segments for qualified interpreting-physician review; it is not primary breast-cancer interpretation or a standalone diagnostic or treatment decision tool.

Modality
Mammography/DBT
Anatomy
Breast; breast arterial calcifications
Decision
2023-10-05
FDA-cleared K231398

VUNO Med-DeepBrain

VUNO Inc.

Authorized purpose: Automate labeling, visualization, and volumetric quantification of segmentable brain structures from MR images for trained medical-imaging professionals.

Modality
MRI
Anatomy
Brain, including segmentable cortical/subcortical structures, vessels, and WMH/lesion regions.
Decision
2023-10-04
FDA-cleared K232023

Momentum Spine

Momentum Health Inc.

Authorized purpose: The Momentum Spine optical-contour-sensing mobile application quantifies asymmetries and assesses body angles and curve progression related to postural asymmetries, including scoliosis. It is available over the counter or by prescription for patients aged 8 years and older.

Modality
Optical Surface Imaging
Anatomy
Torso and spine; postural asymmetry and scoliosis
Decision
2023-10-04
FDA-cleared K232712

uMI Panorama

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMI Panorama combines PET and CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and fused PET/CT images for qualified healthcare professionals supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation across oncology, cardiology, neurology, and other disorders; its CT subsystem can also perform standalone diagnostic imaging and protocol-governed low-dose lung cancer screening.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2023-10-03
FDA-cleared K230045

HipCheck

Stryker Corp.

Authorized purpose: HipCheck assists surgeons with quantitative measurements for femoroacetabular-impingement procedures by processing intraoperative static fluoroscopic images and superimposing virtual measurement tools for skeletally mature patients. HipMap FAI Analysis provides a patient-specific report for surgeon or radiologist preoperative decision-making with morphological measurements and visualizations of hip impingement and stability.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Hip; femoral head and neck; femoroacetabular impingement
Decision
2023-09-29
FDA-cleared K230252

OFIX MIS App

Orthofix US LLC

Authorized purpose: The OFIX MIS App assists healthcare professionals in viewing, storing, and measuring images and planning orthopedic surgeries, including measurements for placement of surgical implants.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Patient-specific orthopedic surgical anatomy and implant-placement landmarks
Decision
2023-09-26
FDA-cleared K223659

Jazz

AI Medical AG

Authorized purpose: Jazz semi-automatically labels, visualizes, and quantifies segmentable brain structures on MR for patients with known multiple sclerosis and/or brain metastasis, with physician-reviewed/correctable annotations and radiological report output.

Modality
MRI
Anatomy
Brain
Decision
2023-09-22
FDA-cleared K231149

qXR-CTR

Qure.ai Technologies

Authorized purpose: Automated measurement of cardiac diameter, thoracic diameter, and the cardiothoracic ratio (CTR) on posterior-anterior chest X-rays to aid physicians or licensed practitioners; not a stand-alone decision tool.

Modality
X-ray/Radiography
Anatomy
Heart and thoracic cavity
Decision
2023-09-22
FDA-cleared K220034

NEUROShield

In-Med Prognostics L3C

Authorized purpose: NEUROShield labels, visualizes, and quantifies hippocampal volume from brain MRI as decision support for neurologists and neuroradiologists.

Modality
MRI
Anatomy
Brain
Decision
2023-09-14
FDA-cleared K223180

AIRAscore

AIRAmed GmbH

Authorized purpose: AIRAscore automatically labels, visualizes and quantifies segmentable brain structures from MR images, replacing manual volume measurement and providing reference-adjusted reports and annotated images for expert physician evaluation.

Modality
MRI
Anatomy
Brain
Decision
2023-08-25
FDA-cleared K231572

uMI Panorama

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMI Panorama GS combines 148 cm axial-field-of-view PET with CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and registered or fused PET/CT images supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation in oncology, cardiology, neurology, inflammation, infection, and other disorders. The CT subsystem can also perform standalone diagnostic imaging and protocol-governed low-dose lung cancer screening.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2023-07-26
FDA-cleared K230913

ANDI

Imeka Solutions, Inc.

Authorized purpose: ANDI processes diffusion-weighted MRI with auxiliary T1 imaging to create 3D white-matter tract maps and microstructure reports for trained medical professionals as adjunctive measurement information, not diagnosis.

Modality
MRI
Anatomy
Brain
Decision
2023-07-25
FDA-cleared K231668

Spine CAMP™ (1.1)

Medical Metrics, Inc.

Authorized purpose: Analyze spine X-rays to produce static and/or motion metrics from sagittal lumbar and/or cervical radiographs, visualize intervertebral motion through image-registration stabilization, and support assessment of spinal stability, alignment, degeneration, fusion, motion preservation, and implant performance in skeletally mature patients aged 18 years and older.

Modality
X-ray/Radiography
Anatomy
Spine, including sagittal lumbar and cervical spine; femoral-head landmarks for spinopelvic measurements
Decision
2023-07-07
FDA-cleared K222745

Axial3D Insight

Axial Medical Printing Limited

Authorized purpose: Axial3DInsight is a cloud-based service and image-segmentation framework that transfers DICOM imaging information from a medical scanner to an output file for additive-manufactured physical replicas, treatment planning, or diagnostic use in the labeled orthopedic trauma, orthopedic, maxillofacial, and cardiovascular fields.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Patient-specific anatomy in orthopedic trauma, orthopedic, maxillofacial, and cardiovascular applications
Decision
2023-07-03
FDA-cleared K230346

Voluson SWIFT; Voluson SWIFT+

GE Medical Systems Ultrasound & Primary Care Diagnostic, LLC

Authorized purpose: Voluson SWIFT and Voluson SWIFT+ are general-purpose diagnostic ultrasound systems for qualified and trained healthcare professionals to image, measure, display, and analyze the human body and fluid across the labeled fetal/obstetric, abdominal, pediatric, small-organ, cephalic, cardiac, vascular, musculoskeletal, transrectal, and transvaginal applications in a hospital or medical clinic.

Modality
Ultrasound
Anatomy
Fetal/obstetric, abdominal, renal, gynecologic/pelvic, pediatric, breast, testes, thyroid, cephalic, cardiac, vascular, musculoskeletal, transrectal, urologic, and transvaginal anatomy
Decision
2023-06-20
FDA-cleared K231459

HepaFatSmart (V2.0.0)

Resonance Health Analysis Services Pty Ltd

Authorized purpose: Provide quantitative volumetric liver fat fraction, proton-density fat fraction, and steatosis grading to support clinical diagnosis and subsequent management decisions for confirmed or suspected fatty liver disease or metabolic syndromes and to aid living-donor liver-transplant assessment and screening, with results interpreted by a trained physician.

Modality
MRI
Anatomy
Liver
Decision
2023-06-20
FDA-cleared K223556

DeepCatch

MEDICALIP Co., Ltd

DeepCatch analyzes whole-body CT images to segment skin, bone, muscle, visceral fat, subcutaneous fat, internal organs, and central nervous system structures, then calculates volumes, proportions, and three-dimensional models for physician confirmation.

Modality
CT/CTA
Anatomy
Multi-region
Decision
2023-06-16
FDA-cleared K223646

IB Lab LAMA

IB Lab GmbH

Authorized purpose: Automatically measures limb-length discrepancy and quantitative knee-alignment parameters on AP full-leg radiographs.

Modality
X-ray/Radiography
Anatomy
Lower limb/full leg and knee alignment
Decision
2023-06-16
FDA-cleared K230112

CAC Software

Imbio, Inc.

Authorized purpose: Provides non-invasive post-processing to quantify possible coronary calcifications and output Agatston score, arterial age, mass, and volume.

Modality
CT/CTA
Anatomy
Heart and coronary arteries
Decision
2023-06-13
FDA-cleared K223855

FEops HEARTguideTM, FEops HEARTguideTM ALPACA

FEops nv

Authorized purpose: Enable visualization and measurement of heart and vessel structures for preprocedural planning and sizing of structural-heart interventions, including LAAO and TAVI; qualified clinicians use the results with clinical history, symptoms, other evaluations, and professional judgment, and the results do not replace implant-device instructions for final device selection or placement.

Modality
CT/CTA
Anatomy
Heart and cardiovascular vessels, including the left atrium, left atrial appendage, aortic root/ascending aorta, and left ventricle
Decision
2023-06-06
FDA-cleared K220437

Neurophet AQUA

NEUROPHET, Inc.

Authorized purpose: Automatic labeling, visualization, and volumetric quantification of segmentable brain structures from MR images, with optional comparison of volumetric data to reference percentile data; a support tool for structural-MRI assessment.

Modality
MRI
Anatomy
Segmentable brain structures.
Decision
2023-05-10
FDA-cleared K230082

Auto Segmentation

GE Medical Systems, LLC

Authorized purpose: Auto Segmentation generates initial DICOM RT Structure Set contours for 40 organs or subregions from adult contrast or noncontrast CT across head and neck, thorax, abdomen, and pelvis; qualified radiotherapy staff must review labels and edit contours before planning.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2023-05-04
FDA-cleared K230977

SIS System

Surgical Information Sciences, Inc.

Authorized purpose: SIS System fuses clinical brain MRI with postoperative CT to visualize DBS anatomy, localize STN, GPe, and GPi, and segment implanted leads for professional review.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Brain
Decision
2023-05-02
FDA-cleared K230552

MR DWI/FLAIR Measurement V1.0

Olea Medical

Authorized purpose: MR DWI/FLAIR Measurement V1.0 processes brain DWI and FLAIR MRI to calculate ADC maps, segment ADC-hypointense regions, and communicate relative or normalized FLAIR measurements; it is an adjunct and cannot be used alone for diagnosis, treatment, or patient-management decisions.

Modality
MRI
Anatomy
Brain
Decision
2023-04-26
FDA-cleared K222676

Ceevra Reveal 3

Ceevra, Inc.

Authorized purpose: Ceevra Reveal 3 processes, reviews, analyzes, communicates, and interchanges multidimensional CT and MR images for preoperative planning and intraoperative display, with preliminary machine-learning segmentations of selected normal anatomy for adult patients aged 22 years and older.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Patient-specific anatomy represented in CT or MR; normal anatomy used by supported segmentation models
Decision
2023-04-25
FDA-cleared K230223

iCAC Device

Bunkerhill, Inc

Authorized purpose: Adjunctive opportunistic coronary-calcium estimation during routine chest CT review, providing informational segmentation and Agatston estimates for physician assessment rather than a stand-alone diagnosis.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2023-04-25
FDA-cleared K222360

AI-Rad Companion (Cardiovascular)

Siemens Medical Solutions U.S.A.

Authorized purpose: Adjunctive cardiovascular review for radiologists and physicians in emergency medicine, specialty care, urgent care and general practice, including heart volume, coronary calcium volume, aortic segmentation, aortic diameter measurement and threshold-based highlighting of enlarged diameters.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2023-04-06
FDA-cleared K223774

Contour ProtégéAI

MIM Software Inc.

Authorized purpose: Contour ProtegeAI assists trained medical professionals with automated processing of CT and MR images, machine-learning contour creation for quantitative analysis, adaptive therapy, transfer to radiation-treatment planning systems, and archiving, segmentation across CT locations, and segmentation of the prostate, seminal vesicles, and urethra on T2-weighted MR images.

Modality
Radiotherapy Planning Imaging
Anatomy
CT anatomic locations and the prostate, seminal vesicles, and urethra on T2-weighted MR
Decision
2023-04-06
FDA-cleared K222312

RayStation 12A

RaySearch Laboratories AB (publ)

Authorized purpose: RayStation 12A is configurable software for radiation therapy and medical oncology that proposes treatment plans from user input. Authorized users may use reviewed and approved plans to support treatment administration; the system includes image handling, contouring, treatment planning and optimization, dose calculation and evaluation, machine commissioning, treatment interfaces, and machine-learning segmentation or planning functions.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2023-03-29
FDA-cleared K222174

RadioLens v1.0

Synapsica

Authorized purpose: RadioLens v1.0 is a medical diagnostic application for displaying, processing, storing, and transferring DICOM data other than mammography, with filtering, digital manipulation, and quantitative measurements; its optional SpindleX module analyzes potential vertebral displacement in adult cervical or lumbar spine stress X-rays and calculates measurements related to spinal-ligament injury leading to subluxation.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Spine, including cervical and lumbar vertebrae; general DICOM images excluding mammography
Decision
2023-03-28
FDA-cleared K222746

Overjet Caries Assist

Overjet, Inc.

Authorized purpose: Concurrent-read CADe to aid professionally trained and licensed dentists in detecting and segmenting caries on bitewing and periapical radiographs; the output is additional information and does not replace dentist review or clinical judgment.

Modality
X-ray/Radiography
Anatomy
Permanent dentition and tooth surfaces in dental/maxillofacial anatomy
Decision
2023-03-27
FDA-cleared K222036

MPXA-2000

Medipixel, Inc.

Authorized purpose: Quantified results from X-ray angiographic images of the coronary arteries to support clinical decisions about diagnosis or treatment evaluation in adult patients with coronary artery disease; results are not the sole basis for diagnosis.

Modality
X-ray/Radiography
Anatomy
Coronary arteries and cardiovascular anatomy
Decision
2023-03-22
FDA-cleared K223325

uMI Panorama

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMI Panorama combines PET and CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and fused PET/CT images for qualified healthcare professionals supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation across oncology, cardiology, neurology, and other disorders; its CT subsystem can also perform standalone diagnostic imaging and protocol-governed low-dose lung cancer screening.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2023-03-10
FDA-cleared K223514

Spectral Bone Marrow

GE Medical Systems, LLC

Authorized purpose: Automatically segments bone to optimize visualization of bone marrow in spectral body and extremity CT for review of traumatic and non-traumatic bone pathologies.

Modality
CT/CTA
Anatomy
Bone and bone marrow in body and extremity studies
Decision
2023-03-09
FDA-cleared K221680

Xeleris V Processing and Review System

GE Healthcare

Authorized purpose: The Xeleris V Processing and Review System displays, processes, archives, prints, reports, and networks planar, SPECT, and PET nuclear-medicine data, with optional applications for DaTQUANT, lung analysis, brain analysis, coronary-flow reserve, prostate-cancer bone metastases, liver shunt and dose calculations, and monitoring of patient radiation doses from nuclear-medicine imaging data.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body, lung, brain, liver, cardiac, coronary, and other anatomy represented in labeled nuclear-medicine studies
Decision
2023-03-01
FDA-cleared K222970

LVivo IQS

DiA Imaging Analysis Ltd

Non-invasive processing of ultrasound images to detect, measure, and calculate medical parameters of structures and function in patients with suspected disease, with Quality Score feedback; the submitted IQS module provides real-time quality scoring for the left ventricle from the four-chamber apical view.

Modality
Ultrasound
Anatomy
Heart; left ventricle from the four-chamber apical view
Decision
2023-02-01
FDA-cleared K223396

Rapid RV/LV

iSchema View Inc.

Authorized purpose: Adjunctive measurement of the RV/LV ratio as a clinical metric used by medical professionals to quantify severity of right-heart strain in adults evaluated with CTPA; the annotated measurements support, but do not replace, clinical assessment.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2023-02-01
FDA-cleared K222406

Clarius AI

Clarius Mobile Health Corp.

Authorized purpose: Semi-automatic caliper placement for non-invasive musculoskeletal tendon-thickness measurements on ultrasound data.

Modality
Ultrasound
Anatomy
Plantar fascia/foot, Achilles tendon/ankle, and patellar tendon/knee.
Decision
2023-01-23
FDA-cleared K222593

TruPlan Computed Tomography (CT) Imaging Software

Circle Cardiovascular Imaging, Inc.

Authorized purpose: Visualization, measurement, pre-procedural planning and sizing, and post-procedural evaluation for left atrial appendage closure (LAAC); the software is a planning and assessment aid and not a diagnostic replacement.

Modality
CT/CTA
Anatomy
Left atrial appendage and adjacent cardiac and extracardiac cardiovascular structures
Decision
2023-01-18
FDA-cleared K214036

AVIEW

Coreline Soft Co.,Ltd.

Authorized purpose: AVIEW provides quantitative CT analysis of pulmonary and cardiac anatomy, including lung, lobe, airway, fissure, nodule, coronary calcium, and related measurements and reports to support physician review in adults.

Modality
CT/CTA
Anatomy
Lungs, lobes, airways, fissures, heart, coronary arteries, and pulmonary nodules
Decision
2022-12-23
FDA-cleared K223268

BrainInsight

Hyperfine, Inc.

Authorized purpose: Automatically labels, measures, and quantifies brain structures from specified low-field MR images.

Modality
MRI
Anatomy
Brain
Decision
2022-12-16
FDA-cleared K222428

Syngo Dynamics (Version VA40F)

Siemens Medical Solutions USA, Inc.

Authorized purpose: Syngo Dynamics VA40F is a multimodality, vendor-agnostic cardiology image and information system for medical-image management and processing, with post-processing functions for image manipulation and quantification supporting interpretation and analysis for disease detection, diagnosis, and patient management within a healthcare institution's network.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Anatomy represented in multimodality cardiology medical images, excluding U.S. digital mammography diagnosis
Decision
2022-11-14
FDA-cleared K220408

AVIEW RT ACS

Coreline Soft Co.,Ltd

Authorized purpose: AVIEW RT ACS is a medical image-management and processing system for radiation-treatment planning with deep-learning auto-segmentation evidence described in the exact FDA decision material; the submission compares automated organ segmentation with a predicate using Dice similarity coefficient and 95% Hausdorff distance on CT cases.

Modality
Radiotherapy Planning Imaging
Anatomy
Organs at risk across breast, head and neck, abdomen, and pelvis CT validation cases, including lung, heart, eyes, brain, mandible, kidneys, liver, femur, and bladder
Decision
2022-11-10
FDA-cleared K222361

AI-Rad Companion (Musculoskeletal)

Siemens Medical Solutions USA, Inc.

AI-Rad Companion (Musculoskeletal) is an image processing software that provides quantitative and qualitative analysis from previously acquired Computed Tomography DICOM images to support radiologists and physicians from emergency medicine, specialty care, urgent care, and general practice in the evaluation and assessment of musculoskeletal disease. It provides the following functionality: • Segmentation of vertebras • Labelling of vertebras • Measurements of heights in each vertebra and indication if they are critically different • Measurement of mean Hounsfield value in volume of interest within vertebra. Only DICOM images of adult patients are considered to be valid input.

Modality
CT/CTA
Anatomy
Spine
Decision
2022-10-20
FDA-cleared K211611

QIR Suite

CASIS Cardiac Simulation & Imaging Software

Authorized purpose: View, post-process, and quantitatively evaluate cardiovascular MR images in DICOM format.

Modality
MRI
Anatomy
Cardiovascular/heart and aorta
Decision
2022-09-30
FDA-cleared K221738

NS-HGlio

Neosoma Inc.

Authorized purpose: Semi-automatic labeling, visualization, and volumetric quantification of high-grade brain glioma, including WHO grade 3 astrocytoma, grade 4 astrocytoma, and grade 4 glioblastoma, from standard MRI in patients aged 18 or older with pathologically proven high-grade glioma; prior measurements may be compared when available, but the device is not for primary diagnosis.

Modality
MRI
Anatomy
Brain; high-grade glioma and its subcomponents
Decision
2022-09-27
FDA-cleared K213960

LiverMultiScan v5 (LMSv5)

Perspectum

Authorized purpose: LiverMultiScan v5 (LMSv5) is indicated for use as a magnetic resonance diagnostic device software application for noninvasive liver evaluation that enables the generation, display and review of 2D magnetic resonance medical image data and pixel maps for MR relaxation times.LMSv5 is designed to utilize DICOM 3.0 compliant magnetic resonance image datasets, acquired from compatible MRSystems, to display the internal structure of the abdomen including the liver. Other physical parameters derived from the images may also be produced.LMSv5 provides several tools, such as automated liver segmentation and region of interest (ROI) placements, to be used for the assessment of selected regions of an image. Quantitative assessment of selected regions includes the determination of triglyceride fat fraction in the liver (PDFF), T2*, LIC (Liver Iron Concentration) and iron corrected T1(cT1) measurements. These images and the physical parameters derived from the images, when interpreted by a trained clinician, yield information that may assist in diagnosis.

Modality
MRI
Anatomy
Liver
Decision
2022-09-06
FDA-cleared K221100

Viz RV/LV

Viz.ai, Inc.

Authorized purpose: Measures maximal right- and left-ventricular diameters from volumetric CTPA and reports their ratio.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2022-08-29
FDA-cleared K222172

MI View&GO

Siemens Medical Solutions USA, Inc.

Authorized purpose: MI View&GO is a multimodality medical-image application for viewing, manipulating, quantifying, analyzing, and comparing PET, SPECT, CT, and MR images across time points in oncology, cardiology, neurology, organ-function, and radiotherapy-planning workflows.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Whole body, organs, tumors, heart, brain, and oncology regions
Decision
2022-08-19
FDA-cleared K213713

AI-Rad Companion (Pulmonary)

Siemens Healthcare GmBh

AI-Rad Companion (Pulmonary) is image processing software that provides quantitative and qualitative analysis from previously acquired Computed Tomography DICOM images to support radiologists and physicians from emergency medicine, specialty care, urgent care, and general practice in the evaluation and assessment of disease of the lungs. It provides the following functionality: Segmentation and measurements of complete lung and lung lobes Identification of areas with lower Hounsfield values in comparison to a predefined threshold for complete lung and lung lobes Providing an interface to external Medical Device syngo.CT Lung CAD Segmentation and measurements of solid lung nodules. Dedication of found lung nodules to corresponding lung lobe. Correlation of segmented lung nodules of current scan with known priors and quantitative assessment of changes of the correlated data. Identification of areas with elevated Hounsfield values, where areas with elevated versus high opacities are distinguished. The software has been validated for data from Siemens Healthineers (filtered back projection and iterative reconstruction),GE Healthcare (filtered back projection reconstruction), and Philips (filtered back projection reconstruction).Only DI COM images of adult patients are considered to be valid input.

Modality
CT/CTA
Anatomy
Chest/Lung
Decision
2022-08-11
FDA-cleared K221432

Customize

3D-Side SA

Customize supports adult total ankle arthroplasty planning with CT segmentation, 3D models, implant positioning and sizing, plan review, and X-ray-informed planning.

Modality
CT/CTA
Anatomy
Foot/Ankle
Decision
2022-08-03
FDA-cleared K213760

ABMD Software

HeartLung Corporation

Authorized purpose: The Automated Bone Mineral Density Software Module measures bone mineral density from existing CT by averaging Hounsfield units in trabecular vertebral bone and can calculate age- and sex-referenced Z and T scores.

Modality
CT/CTA
Anatomy
Trabecular vertebral bone and lumbar spine
Decision
2022-07-29
FDA-cleared K213998

cvi42 Auto Imaging Software Application

Circle Cardiovascular Imaging Inc

Authorized purpose: Viewing, post-processing, qualitative and quantitative evaluation, cardiac measurements, calcium scoring, and evaluation of physician-identified vascular lesions in cardiovascular MR/CT images.

Modality
CT/CTA; MRI
Anatomy
Heart and adjacent cardiovascular vessels
Decision
2022-07-28
FDA-cleared K220624

AI4CMR v1.0

AI4MedImaging Medical Solutions S.A.

Authorized purpose: Automatic segmentation and reporting of cardiac function measurements from 1.5T and 3T MR images to support clinical decision-making; results are not intended for standalone clinical decision-making.

Modality
MRI
Anatomy
Heart, including left and right ventricles, myocardium, and cardiac chambers
Decision
2022-07-22
FDA-cleared K220882

Vivid E80, Vivid E90, Vivid E95

GE Medical Systems Ultrasound and

Authorized purpose: Vivid E80, Vivid E90, and Vivid E95 are general-purpose diagnostic ultrasound systems with specialized cardiac applications for imaging, measurement, display, and analysis across the labeled adult, pediatric, fetal, vascular, procedural, and other ultrasound applications.

Modality
Ultrasound
Anatomy
Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal; thoracic; and urologic anatomy
Decision
2022-07-22
FDA-cleared K220956

Libby Echo:Prio

Dyad Medical, Inc

Authorized purpose: Process previously acquired DICOM-compliant cardiac ultrasound images and estimate cardiac measurements to support qualified cardiologists, sonographers, or other licensed professional healthcare practitioners in clinical decision-making; indicated for adults.

Modality
Ultrasound
Anatomy
Heart and cardiovascular structures, including LV chamber/endocardium, LA, and LV myocardium
Decision
2022-07-20
FDA-cleared K220815

BrainInsight

Hyperfine, Inc.

Authorized purpose: Automatically labels, spatially measures, and volumetrically quantifies brain structures from low-field MR images and returns annotated/segmented images, color overlays, and reports.

Modality
MRI
Anatomy
Brain
Decision
2022-07-19
FDA-cleared K221727

syngo.CT Extended Functionality

Siemens Medical Solutions USA, Inc.

Authorized purpose: syngo.CT Extended Functionality provides advanced visualization and processing tools for CT-acquired or reconstructed data, including labeled vessel, spectral, pulmonary, oncology, nodule, trauma, measurement, and analysis workflows under professional review.

Modality
CT/CTA
Anatomy
Vessels, lungs, nodules, oncology, trauma, and other anatomy represented in CT studies
Decision
2022-07-13
FDA-cleared K220497

CoLumbo

Smart Soft Healthcare AD

Authorized purpose: CoLumbo is an image post-processing and measurement software tool that provides quantitative spine measurements from previously-acquired DICOM lumbar spine Magnetic Resonance (MR) images for users' review, analysis, and interpretation. It provides the following functionality to assist users in visualizing, measuring and documenting out-of range measurements:- Feature segmentation;- Feature measurement;- Threshold-based labeling of out-of-range measurement; and- Export of measurement results to a written report for user's review, revise and approval. Columbo does not produce or recommend any type of medical diagnosis or treatment. Instead, it simply helps users to more easily identify and classify features in lumbar MR images and compile a report. The user is responsible forconfirming/modifying settings, reviewing and verifying the software-generated measurements, inspecting out-of-range measurements, and approving draft report content using their medical judgment and discretion. The device is intended to be used only by hospitals and other medical institutions. Only DICOM images of MRI acquired from lumbar spine exams of patients aged 18 and above are considered to be valid input. CoLumbo does not support DICOM images of patients that are pregnant, undergo MRI scan with contrast media, or have post-operational complications, scoliosis, tumors, infections, fractures.

Modality
MRI
Anatomy
Spine
Decision
2022-06-23
FDA-cleared K221463

ElucidVivo A.3

Elucid Bioimaging Inc.

Authorized purpose: ElucidVivo A.3 postprocesses contrast multidetector CT to visualize arterial vessels and provide semi-automatic lumen boundaries, stenosis and lumen measurements, vessel length, and related values to assist trained physicians in atherosclerosis stratification; measurements complement standard care and are not diagnoses or recommendations.

Modality
CT/CTA
Anatomy
Arterial vessels and atherosclerotic disease
Decision
2022-06-17
FDA-cleared K221248

Rapid LVO

iSchemaView Inc.

Authorized purpose: Assist hospital networks and trained radiologists with workflow triage by flagging and communicating suspected ICA or MCA-M1 large-vessel occlusion findings in head CTA images.

Modality
CT/CTA
Anatomy
Head/brain vasculature, specifically the intracranial ICA and MCA-M1 segments.
Decision
2022-05-31
FDA-cleared K221106

Quantib Prostate

Quantib BV

Authorized purpose: Quantib Prostate versions 1.0 and 2.0 provide processing, visualization, editing, registration, mathematical or statistical analysis, semi-automatic segmentation, volume computation, and PI-RADS workflow support for prostate MRI. The software provides information that may assist trained medical professionals in interpreting prostate MR studies, and diagnosis must not be made solely from its analysis.

Modality
MRI
Anatomy
Prostate; prostate and prostatic sub-regions
Decision
2022-05-13
FDA-cleared K220446

Versana Balance

GE Medical Systems Ultrasound and Primary Care Diagnostics

Authorized purpose: Versana Balance is a general-purpose diagnostic ultrasound system for imaging, measurement, display, and analysis of the human body and body fluids across the labeled fetal, abdominal, gynecologic, pediatric, small-organ, cardiac, vascular, musculoskeletal, thoracic, and interventional applications.

Modality
Ultrasound
Anatomy
Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal; thoracic; and urologic anatomy
Decision
2022-05-11
FDA-cleared K212519

Overjet Caries Assist

Overjet, Inc.

Authorized purpose: Overjet Caries Assist is a concurrent-read aid for detecting and segmenting caries on bitewing radiographs of permanent dentition in patients aged 18 years and older; it provides additional information for a dentist and is not a replacement for complete review or clinical judgment.

Modality
X-ray/Radiography
Anatomy
Permanent dentition; tooth surfaces and caries
Decision
2022-05-10
FDA-cleared K211966

Segment 3DPrint

Medviso AB

Authorized purpose: Segment 3DPrint reviews and segments images from medical scanners and medical 3D models to generate 3D models for diagnostic visualization, measurement, treatment planning, and additive-manufacturing support in pediatric and adult orthopedic, maxillofacial, and cardiovascular workflows.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Orthopedic, maxillofacial, cardiovascular, and other patient-specific anatomy represented in medical images
Decision
2022-05-06
FDA-cleared K212915

MVision AI Segmentation

MVision AI

Authorized purpose: MVision AI Segmentation automatically generates initial contours from CT images for radiotherapy planning; the contours are transferred for professional visualization, review, modification, and approval, and the labeled software is not intended for lesion or tumor detection or real-time adaptive planning.

Modality
Radiotherapy Planning Imaging
Anatomy
Head and neck, brain, breast, lung and abdomen, male pelvis, and female pelvis structures
Decision
2022-05-03
FDA-cleared K220590

aPROMISE X

EXINI Diagnostics AB

Authorized purpose: aPROMISE X accepts, stores, displays, manipulates, quantifies, and reports digital medical images from nuclear-medicine imaging using PSMA PET/CT, with tools for marking regions of interest and quantitative oncology review by healthcare professionals or researchers.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole-body oncology anatomy represented in PSMA PET/CT studies
Decision
2022-04-29
FDA-cleared K220264

EFAI RTSuite CT HN-Segmentation System

Ever Fortune.AI Co., Ltd.

Authorized purpose: EFAI RTSuite CT HN-Segmentation System automatically delineates head-and-neck organs at risk on adult non-contrast CT images to support radiation-treatment workflows; initial contours are transferred to a DICOM-compliant treatment-planning system for professional review and editing.

Modality
Radiotherapy Planning Imaging
Anatomy
Head and neck organs at risk
Decision
2022-04-28
FDA-cleared K213944

HealthOST

NanoxAI Ltd.

Authorized purpose: Qualitative and quantitative spine analysis from CT images to support clinician evaluation of musculoskeletal spinal disease, including vertebral labeling, vertebral height-loss measurement, and mean vertebral Hounsfield-unit measurement in patients aged 50 and over.

Modality
CT/CTA
Anatomy
Spine, including T1-L4 vertebrae and T11-L4 trabecular bone regions
Decision
2022-04-22
FDA-cleared K213706

AI-Rad Companion Brain MR

Siemens Healthcare GmBh

Authorized purpose: AI-Rad Companion Brain MR VA40 post-processes head MR images to segment and quantify brain structures and white-matter hyperintensities, compare normalized values with healthy reference data, and return visual and numeric reports for clinician review.

Modality
MRI
Anatomy
Brain
Decision
2022-04-15
FDA-cleared K212274

INT Contour

Carina Medical LLC

Authorized purpose: INT Contour uses a machine-learning approach to provide initial segmentation and contouring of treatment targets and organs at risk for radiation-treatment planning; qualified dosimetrists, physicists, and radiation oncologists must review and edit results when necessary.

Modality
Radiotherapy Planning Imaging
Anatomy
Head and neck, thorax, abdomen, and male pelvis
Decision
2022-04-08
FDA-cleared K203783

ClariPulmo

ClariPi Inc.

Authorized purpose: Non-invasive CT image analysis that quantifies lung images and supports physician review of pulmonary tissue images and abnormalities.

Modality
CT/CTA
Anatomy
Chest/Lung; lungs/pulmonary tissue
Decision
2022-04-06
FDA-cleared K212624

EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment System

Ever Fortune. AI Co., Ltd.

Authorized purpose: Automatic cardiothoracic-ratio assessment on PA chest X-ray images for adults 20-80 years old in healthcare institutions; results support clinician assessment and are not for standalone clinical decision-making.

Modality
X-ray/Radiography
Anatomy
Heart and thoracic cavity for cardiothoracic-ratio measurement
Decision
2022-04-04
FDA-cleared K213779

Customize

3D-Side SA

Authorized purpose: Customize supports adult shoulder arthroplasty planning with CT segmentation, three-dimensional models, implant positioning and sizing, case management, and physician approval; it is not for diagnosis, spine surgery, or implant and instrument design.

Modality
CT/CTA
Anatomy
Shoulder
Decision
2022-03-16
FDA-cleared K203744

Arterys MICA

Arterys Inc.

Authorized purpose: Manages, views, processes, stores, transfers, filters, manipulates, and quantitatively measures DICOM and non-DICOM images and data, with optional Cardio AI and Oncology AI support.

Modality
CT/CTA; MRI
Anatomy
Multi-region
Decision
2022-03-14
FDA-cleared K213725

CardIQ Suite

GE Medical Systems SCS

Cardiac CT software for visualization, measurement, and calcium scoring to support clinician-led cardiovascular assessment.

Modality
CT/CTA
Anatomy
Heart and cardiovascular anatomy, including vessels, chambers, coronary arteries, heart valves, and great vessels such as the aorta.
Decision
2022-03-11
FDA-cleared K213976

Contour ProtégéAI

MIM Software Inc.

Authorized purpose: Contour ProtégéAI creates machine-learning contours from CT and MR DICOM images to support quantitative analysis, adaptive therapy, radiotherapy planning, archiving, and follow-up; professionals must visualize, review, and edit contours, and the software is not intended to detect or contour lesions.

Modality
Radiotherapy Planning Imaging
Anatomy
Normal structures in labeled CT locations; prostate, seminal vesicles, and urethra on T2 MR
Decision
2022-02-03
FDA-cleared K214019

syngo.CT Extended Functionality

Siemens Medical Solutions USA, Inc.

Authorized purpose: syngo.CT Extended Functionality provides advanced visualization and processing of CT-acquired or reconstructed data, with labeled trauma, spectral, vascular, pulmonary, oncology, segmentation, measurement, and analysis tools that support professional diagnosis.

Modality
CT/CTA
Anatomy
Trauma, vessels, lungs, oncology, and other anatomy represented in CT or MR studies
Decision
2022-01-20
FDA-cleared K213737

Quantib ND

Quantib B.V.

Authorized purpose: Automatic labeling, visualization, and volumetric quantification of segmentable brain structures from MR images, with complementary segmentations, visualizations, and volume measurements for trained professionals evaluating MR brain images and preparing quantitative reports.

Modality
MRI
Anatomy
Brain structures and white matter hyperintensities
Decision
2022-01-14
FDA-cleared K213544

TOMTEC-ARENA

TOMTEC Imaging Systems GmbH

Authorized purpose: TOMTEC-ARENA TTA2.50 analyzes ultrasound to quantify and report cardiovascular, fetal, and abdominal structures and functions, including editable AI-assisted echocardiographic measurements.

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2022-01-06
FDA-cleared K213776

LiverSmart

Resonance Health Analysis Services Pty Ltd

Authorized purpose: Measures liver iron concentration for specified iron-overload and thalassemia/sickle-cell indications; assesses VLFF, PDFF, and steatosis grade for suspected or confirmed fatty liver disease; physician-interpreted results may support weight-loss monitoring and living-donor assessment.

Modality
MRI
Anatomy
Liver
Decision
2021-12-29
FDA-cleared K212616

Koios DS

Koios Medical, Inc.

Authorized purpose: Koios DS is an artificial intelligence (AI)/machine learning (ML)-based computer-aided diagnosis (CADx) software device intended for use as an adjunct to diagnostic ultrasound examinations of lesions or nodules suspicious for breast or thyroid cancer. Koios DS allows the user to select or confirm regions of interest (ROIs) within an image representing a single lesion or nodule to be analyzed. The software then automatically characterizes the selected image data to generate an AI/ML-derived cancer risk assessment and selects applicable lexicon-based descriptors designed to improve overall diagnostic accuracy as well as reduce interpreting physician variability. Koios DS may also be used as an image viewer of multi-modality digital images, including ultrasound and mammography. The software includes tools that allow users to adjust, measure and document images, and output into a structured report. Koios DS software is designed to assist trained interpreting physicians in analyzing the breast ultrasound images of adult (>= 22 years) female patients with soft tissue breast lesions and/or thyroid ultrasounds of all adult (>= 22 years) patients with thyroid nodules suspicious for cancer. When utilized by an interpreting physician who has completed the prescribed training, this device provides information that may be useful in recommending appropriate clinical management. Limitations: Patient management decisions should not be made solely on the results of the Koios DS analysis. Koios DS software is not to be used for the evaluation of normal tissue, on sites of post-surgical excision, or images with doppler, elastography, or other overlays present in them. Koios DS software is not intended for use on portable handheld devices (e.g. smartphones or tablets) or as a primary diagnostic viewer of mammography images. The software does not predict the presence of the thyroid nodule margin descriptor, extra-thyroidal extension. In the event that this condition is present, the user may select this category manually from the margin descriptor list.

Modality
Ultrasound
Anatomy
Breast
Decision
2021-12-16
FDA-cleared K212466

LVivo Seamless

DiA Imaging Analysis Ltd

Non-invasive processing of ultrasound images to detect, measure, and calculate relevant parameters of structures and function in patients with suspected disease aged over 18.

Modality
Ultrasound
Anatomy
Exact anatomy wording was withdrawn pending re-verification.
Decision
2021-12-09
FDA-cleared K213096

Al-Rad Companion (Pulmonary)

Siemens Medical Solutions USA, Inc.

Authorized purpose: Quantitative and qualitative CT analysis to support radiologists and physicians in emergency medicine, specialty care, urgent care, and general practice in evaluating and assessing lung disease.

Modality
CT/CTA
Anatomy
Lungs, lung lobes, lung lesions, and pulmonary opacity regions within the thorax.
Decision
2021-12-06
FDA-cleared K210831

OnQ Neuro

CorTechs Labs, Inc

Authorized purpose: Analyzes neurological MR images for automated segmentation, volumetric quantification, reporting, fusion, and longitudinal comparison of known pathologically confirmed brain tumors.

Modality
MRI
Anatomy
Brain; pathologically confirmed brain tumors
Decision
2021-11-19
FDA-cleared K211881

AI Segmentation

Varian Medical Systems, Inc.

Authorized purpose: AI Segmentation version 2.0 is a cloud web application that generates initial CT organ-at-risk contours for head and neck, thorax, abdomen, and pelvis for review, editing, and approval in Eclipse treatment-planning workflows; it does not provide clinical decisions or evaluate treatment plans.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2021-09-02
FDA-cleared K203696

RBknee

Radiobotics ApS

Authorized purpose: Measures minimum joint-space width and assesses sclerosis, joint-space narrowing, osteophytes, and radiographic knee osteoarthritis using OARSI and Kellgren-Lawrence criteria.

Modality
X-ray/Radiography
Anatomy
Knee
Decision
2021-08-27
FDA-cleared K211431

breastscape v1.0

Olea Medical

Authorized purpose: Visualization, analysis, reporting, lesion measurement, kinetic assessment, and MR-guided breast interventional planning; when interpreted by a skilled physician, information may support screening, diagnosis, and intervention planning, but patient management must not rely solely on the results.

Modality
Mammography/DBT
Anatomy
Breast lesions and breast morphological landmarks including nipple, chest, and skin borders.
Decision
2021-08-02
FDA-cleared K211222

qER-Quant

Qure.ai Technologies

Automatic labeling, visualization, and quantification of segmentable brain structures from non-contrast head CT, including intracranial hyperdensities, lateral ventricles, and midline shift; single-timepoint volumes and longitudinal comparisons are provided when scans use the same scanner and protocol for the same person.

Modality
CT/CTA
Anatomy
Brain; intracranial hyperdensities, lateral ventricles, and midline shift
Decision
2021-07-30
FDA-cleared K210791

Us2.v1

eko.ai Pte. Ltd. d/b/a Us2.ai

Authorized purpose: Us2.v1 is a fully automated software platform that processes, analyses and makes measurements on acquired transthoracic cardiac ultrasound images, automatically producing a full report with measurements of several key cardiac structural and functional parameters. The data produced by this software is intended to be used to support qualified cardiologists or licensed primary care providers for clinical decision-making. Us2.v1 is indicated for use in adult patients. Us2.v1 has not been validated for the assessment of congenital heart disease, valve disease, pericardial disease, and/or intra-cardiac lesions (e.g. tumors, thrombi). Please note the following limitations: -Poor image capture will lead to poor annotations and subsequent measurements. Multiple image quality algorithms are used to filter out images of poor quality. -Our software complements good patient care and does not exempt the user from the responsibility to provide supervision, clinically review the patient, and make appropriate clinical decisions. -If no gender is present, female referenced guideline values will be used for conclusions. -If Body surface area (BSA) is not present, indexed values cannot be provided. -During image acquisition, inappropriate use of the echo machine, use of non-cardiac ultrasound probes, use of suboptimal settings (e.g. gain, contrast, depth), or lack of electrocardiogram capture may lead to lower accuracy of the software.

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2021-07-27
FDA-cleared K211655

aPROMISE

EXINI Diagnostics AB

Authorized purpose: aPROMISE is a cloud-based platform for healthcare professionals and researchers to accept, transfer, store, display, manipulate, quantify, and report PSMA PET/CT examinations using the PROMISE framework.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Prostate
Decision
2021-07-27
FDA-cleared K211459

syngo.via MI WorkFlows, Scenium, syngo MBF

Siemens Medical Solutions USA, Inc.

Authorized purpose: syngo.via MI WorkFlows, Scenium, and syngo MBF support the viewing, processing, and quantitative review of supported molecular-imaging and cardiac studies in the exact K211459 workflow; modality and application limits follow the FDA submission.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Cardiac, whole-body, and other anatomy represented in supported PET/CT, SPECT, or MR studies
Decision
2021-06-10
FDA-cleared K210187

Overjet Dental Assist

Overjet, Inc.

Overjet Dental Assist is a radiological semi-automated image processing software device intended to aid dental professionals in the measurements of mesial and distal bone levels associated with each tooth from bitewing and periapical radiographs. It should not be used in-lieu of full patient evaluation or solely relied upon to make or confirm a diagnosis. The system is to be used by trained professionals including, but not limited to, dentists and dental hygienists. Intended Patient Population: The intended patient population of the device is patients living in the United States, who are 22 years old or older, and that do not have any remaining primary teeth. Overjet has not evaluated the performance of the device on primary dentition.

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2021-05-19
FDA-cleared K203502

MEDO-Thyroid

MEDO DX Pte. Ltd.

Authorized purpose: Views and quantifies thyroid ultrasound data with machine learning to aid thyroid-lobe analysis and identify, quantify, and document nodules in adults age 18 or older.

Modality
Ultrasound
Anatomy
Thyroid
Decision
2021-04-23
FDA-cleared K203469

AI Segmentation

Varian Medical Systems, Inc.

Authorized purpose: AI Segmentation version 1.0 is a static, cloud-hosted web application that generates initial CT organ-at-risk contours for head and neck, thorax, abdomen, and pelvis for review and approval in Eclipse treatment-planning workflows; this release does not include manual editing tools.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2021-04-19
FDA-cleared K202990

NinesMeasure

Nines, Inc.

Authorized purpose: Provides semi-automatic measurement of pulmonary-nodule size in adult thoracic CT.

Modality
CT/CTA
Anatomy
Chest/Lung
Decision
2021-02-25
FDA-cleared K202212

TruPlan

Circle Cardiovascular Imaging Inc.

Authorized purpose: TruPlan provides CT image processing, visualization, measurements, and cardiac procedure-planning workflow support for the labeled use; exact procedure scope and outputs are release-specific.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2021-02-19
FDA-cleared K203103

Synapse 3D, Synapse 3D Base Tools v6.1

Fujifilm Corporation

Authorized purpose: Synapse 3D Base Tools is medical-imaging software that provides trained medical professionals tools to aid reading, interpreting, reporting, and treatment planning. It accepts DICOM images from imaging devices including CT, MR, CR, US, NM, PT, and XA, and provides viewing, volume rendering, multiplanar reconstruction, fusion, subtraction, segmentation, measurements, annotations, reporting, image management, and modality-specific CT and MR tools. It is not intended for primary diagnostic interpretation of mammography images.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Patient anatomy represented in supported DICOM CT, MR, CR, US, NM, PT, and XA images; mammography excluded
Decision
2021-02-09
FDA-cleared K210053

LVivo Software Application

DiA Imaging Analysis Ltd

Authorized purpose: LVivo Software Application non-invasively processes ultrasound images to detect, measure, and calculate relevant medical parameters of patient structures and function in patients with suspected disease.

Modality
Ultrasound
Anatomy
Structures and function represented in supported ultrasound examinations
Decision
2021-02-05
FDA-cleared K203280

Hepatica v1 (Hepatica v1.0.0)

Perspectum Ltd.

Authorized purpose: Hepatica (Hepatica v1) is a post-processing medical device software that presents quantified metrics which may contribute to the assessment of a patient's liver health. Hepatica (Hepatica v1) uses image visualization and analysis tools to process DICOM 3.0 compliant magnetic resonance image datasets to produce semi-automatic segmented 3D models of the liver based on the work of Couinaud and the Brisbane 2000 terminology. For each identified Couinaud segment, volumetric data is determined and reported. Hepatica (Hepatica v1) may also report iron corrected-T1 (cT1) and PDFF calculated using the IDEAL method from multi-slice acquisitions, on a per segment basis, over the whole liver. Both metrics present numerical values of different fundamental liver tissue characteristics that can be used as measures of liver tissue health. Hepatica (Hepatica v1) provides trained clinicians with additional information to evaluate the volume and health of patient's liver on a segmental basis. It is not intended to replace the established procedures for the assessment of patient's liver health. However, information gathered through existing diagnostic tests, clinical evaluation of the patient, as well Hepatica (Hepatica v1), may support surgical decision making.

Modality
MRI
Anatomy
Liver
Decision
2021-01-12
FDA-cleared K202414

BrainInsight

Hyperfine Research, Inc

Authorized purpose: BrainInsight automatically labels, spatially measures, and volumetrically quantifies brain structures from low-field MR images, returning annotated or segmented images, color overlays, and reports for trained physician review.

Modality
MRI
Anatomy
Brain structures
Decision
2021-01-07
FDA-cleared K193287

CorInsights MRI

ADM Diagnostics, Inc.

Authorized purpose: Automatically labels, visualizes, and volumetrically quantifies segmentable brain structures from MR images with reference-percentile comparison for adults age 45-95.

Modality
MRI
Anatomy
Brain
Decision
2020-11-20
FDA-cleared K201195

syngo.via MI Workflows, syngo MBF

Siemens Medical Solutions USA, Inc.

Authorized purpose: syngo.via molecular-imaging workflows provide viewing, manipulation, quantification, analysis, and comparison of medical images from one or more modalities and time points, including PET or nuclear-medicine functional data and CT or MR anatomical data. The workflows support disease-management activities in oncology, cardiology, neurology, and organ function, and the images or results may aid radiotherapy treatment planning. The submission also describes Scenium neurology review and syngo MBF quantitative myocardial-blood-flow review for supported PET studies.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole-body, cardiac, neurologic, oncologic, organ-function, and radiotherapy-planning anatomy represented in PET, nuclear-medicine, CT, and MR studies
Decision
2020-11-18
FDA-cleared K193306

PROView

GE Medical Systems SCS

Authorized purpose: PROView is an aiding tool for the clinicians to review multi-parametric prostate MR images following PI-RADS guidelines. It displays acquired and reformatted data for visualization and provides tools for assessment of the prostate gland volume and findings analysis in patients with known or suspected prostate lesions. Measurements and associated scoring are included in a report for communication to referring physicians.

Modality
MRI
Anatomy
Prostate
Decision
2020-11-17
FDA-cleared K202501

Quantib Prostate

Quantib BV

Authorized purpose: Quantib Prostate is image post-processing software for processing, visualizing, and editing prostate MRI images. It supports registered multiparametric-MRI viewing, optional combined-image visualization, semi-automatic anatomical segmentation, volume computation, manual editing, and a structured PI-RADS workflow to assist trained medical professionals interpreting prostate MR studies; diagnosis should not be made solely from its analysis.

Modality
MRI
Anatomy
Prostate
Decision
2020-10-11
FDA-cleared K202170

LiverMultiScan

Perspectum LTD

Authorized purpose: LiverMultiScan LMSv4 processes abdominal MRI, including liver images, to generate pixel maps and measurements for proton-density fat fraction, T2 star, and corrected T1, with automated liver segmentation and region-of-interest tools for trained clinician interpretation.

Modality
MRI
Anatomy
Abdomen including liver
Decision
2020-10-02
FDA-cleared K202280

Cleerly Labs v2.0

Cleerly, Inc.

Authorized purpose: Web-based post-processing of cardiac CT data from CCTA performed for CAD or suspected CAD to view and analyze coronary plaques/atherosclerosis and stenosis and support measurement and visualization of coronary arteries.

Modality
CT/CTA
Anatomy
Heart; coronary arteries, plaques, and stenosis
Decision
2020-10-02
FDA-cleared K192051

THINQ

CorticoMetrics LLC

Authorized purpose: Automatically label, visualize, and volumetrically quantify segmentable brain structures from MR images; volumetric measurements may be compared with reference percentile data.

Modality
MRI
Anatomy
Brain, including segmentable brain structures.
Decision
2020-09-30
FDA-cleared K202546

LVivo Seamless

DiA Imaging Analysis Ltd

Authorized purpose: LVivo Seamless non-invasively processes ultrasound images to detect, measure, and calculate relevant medical parameters of patient structures and function in patients with suspected disease.

Modality
Ultrasound
Anatomy
Structures and function represented in supported ultrasound examinations
Decision
2020-09-29
FDA-cleared K201103

Xeleris V Processing and Review Systems

GE Healthcare

Authorized purpose: Xeleris V is intended for nuclear-medicine or radiology practitioners and referring physicians to display, process, archive, print, report, and network nuclear-medicine data from gamma cameras or PET scanners. PET or nuclear-medicine data may be registered or fused with CT or MR and physiologic signals to depict, localize, or quantify radionuclide tracers and anatomical structures. The labeled applications include DaTQUANT review of 123I-ioflupane images, Q.Lung support for pulmonary embolism, COPD, emphysema, lung-function assessment, and resection planning, and Q.Brain review of brain metabolic function or blood flow in specified neurologic conditions.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole-body, lung, brain/striatum, and other anatomy represented in nuclear-medicine, PET, CT, and MR studies
Decision
2020-09-25
FDA-cleared K200851

Vivid T8, Vivid T9

GE Medical Systems Ultrasound and Primary Care Diagnostics

Authorized purpose: Vivid T8 and Vivid T9 are general-purpose ultrasound systems specialized for cardiac imaging and intended for qualified and trained healthcare professionals for ultrasound imaging, measurement, display, and analysis of the human body and fluid. The labeled environment includes hospital echo labs, other hospital settings, operating rooms, catheterization labs, and private medical offices, with fetal, abdominal, pediatric, small-organ, cephalic, cardiac, vascular, musculoskeletal, transcranial, transesophageal, transrectal, transvaginal, interventional, and intraoperative applications.

Modality
Ultrasound
Anatomy
Fetal, abdominal, pelvic, urologic, pediatric, small-organ, cephalic, cardiac, vascular, musculoskeletal, transcranial, transesophageal, transrectal, transvaginal, interventional, and intraoperative anatomy
Decision
2020-09-09
FDA-cleared K200714

AVIEW

Coreline Soft Co., Ltd

Authorized purpose: AVIEW provides CT values for pulmonary tissue from thoracic and cardiac CT datasets and supports quantitative diagnosis, follow-up evaluation, and documentation through lung, lobe, airway, and cardiac segmentation, inspiration-expiration registration, air-trapping analysis, volumetric and density evaluation, nodule characterization, and reporting.

Modality
CT/CTA
Anatomy
Lungs, lobes, airways, pulmonary nodules, and cardiac anatomy
Decision
2020-08-26
FDA-cleared K201632

TOMTEC-ARENA

TOMTEC Imaging Systems GmbH

TOMTEC-ARENA quantifies and reports cardiovascular, fetal, and abdominal structures and functions from supported clinical images and can exchange data with IMAGE-ARENA and third-party applications.

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2020-08-14
FDA-cleared K200743

Vivid E80/ Vivid E90/ Vivid E95

GE Medical Systems Ultrasound and

Authorized purpose: Vivid E80, E90, and E95 are cardiovascular and general diagnostic ultrasound systems; K200743 adds AI-assisted cardiac measurements and Doppler-spectrum recognition, expanded ventricular and atrial function analysis, and qualified application-launch and DICOM-report functions.

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2020-07-23
FDA-cleared K200621

Caption Interpretation Automated Ejection Fraction Software

Caption Health

Authorized purpose: Caption Interpretation Automated Ejection Fraction Software processes previously acquired adult transthoracic cardiac ultrasound images, stores and manipulates images, and measures them using an ultrasound device, personal computer, or compatible DICOM-compliant PACS to provide an automated estimate of left-ventricular ejection fraction that may assist a clinician in cardiac evaluation.

Modality
Ultrasound
Anatomy
Heart; left ventricle; adult cardiac evaluation
Decision
2020-07-22
FDA-cleared K192969

Ezra Plexo Software

Ezra AI Inc.

Authorized purpose: Ezra Plexo Software is a medical diagnostic application for viewing, manipulation, three-dimensional visualization, and comparison of MR medical images. It supports an oncologic workflow by helping the user confirm the absence or presence of lesions, including evaluation, quantification, and documentation; the clinician retains responsibility for diagnosis and the software complements standard review of separate unregistered images.

Modality
MRI
Anatomy
MR images and lesions in oncologic imaging
Decision
2020-07-10
FDA-cleared K193294

AI-Rad Companion Engine

Siemens Medical Solutions USA, Inc.

Authorized purpose: AI-Rad Companion Engine is a software platform that provides basic visualization and enables external post-processing extensions for medical images used for diagnostic purposes. It supports technicians and trained physicians in qualitative and quantitative measurement and analysis, stores data, transfers data to other systems such as PACS, validates DICOM tags, and provides interfaces for clinical extensions.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Medical images and clinical data represented in multimodality DICOM studies
Decision
2020-07-10
FDA-cleared K193252

Contour ProtegeAI

MIM Software Inc.

Authorized purpose: Contour ProtegeAI is used by trained medical professionals as a tool for automated processing of CT and MR medical images. It creates contours with machine-learning algorithms for quantitative analysis, adaptive therapy support, transfer to radiation-treatment planning systems, and archiving, segments normal structures across CT anatomical locations, and segments the prostate, seminal vesicles, and urethra in T2-weighted MR images. It must be used with MIM software to review and, if necessary, edit automatically generated contours.

Modality
Radiotherapy Planning Imaging
Anatomy
Normal structures in CT anatomy; prostate, seminal vesicles, and urethra on T2-weighted MR
Decision
2020-07-02
FDA-cleared K200232

LVivo Software Application

DiA Imaging Analysis Ltd

Authorized purpose: LVivo Software Application processes ultrasound clips and supports the labeled LVivo EF, SG, SAX, RV, and Bladder measurements and analyses, with user review and editing of supported studies.

Modality
Ultrasound
Anatomy
Cardiac structures, right and left ventricles, bladder, and other supported ultrasound anatomy
Decision
2020-06-23
FDA-cleared K193290

AI-Rad Companion Brain MR

Siemens Medical Solutions USA, Inc.

Authorized purpose: AI-Rad Companion Brain MR post-processes typical head-MR T1 MPRAGE images to automatically segment and quantify brain structures, compare normalized volumes with healthy reference data, and present numeric and visual reporting information to clinicians.

Modality
MRI
Anatomy
Brain
Decision
2020-06-17
FDA-cleared K200356

MEDO ARIA

Medo.ai

Authorized purpose: Uses machine learning to view and quantify ultrasound image data to aid trained medical professionals in diagnosing developmental dysplasia of the hip.

Modality
Ultrasound
Anatomy
Hip
Decision
2020-06-11
FDA-cleared K193220

AVIEW LCS

Coreline Soft Co., Ltd

Authorized purpose: AVIEW LCS reviews and analyzes thoracic CT images to characterize lung nodules in a single study or over time, including nodule measurements and release-specific Lung-RADS decision support.

Modality
CT/CTA
Anatomy
Lung
Decision
2020-05-05
FDA-cleared K201012

EPIQ Diagnostic Ultrasound System Series, Affiniti Diagnostic Ultrasound System Series, CX50 Diagnostic Ultrasound System, Sparq Diagnostic Ultrasound System, Lumify Diagnostic Ultrasound System

Philips Ultrasound, Inc.

Authorized purpose: The K201012 labeling covers Philips EPIQ, Affiniti, CX50, Sparq, and Lumify diagnostic ultrasound systems plus QLAB image viewing and quantification for labeled abdominal, cardiac, vascular, obstetric, gynecologic, pediatric, musculoskeletal, small-organ, urologic, intraoperative, and other ultrasound workflows.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2020-05-01
FDA-cleared K192437

Arterys MICA

Arterys Inc.

Authorized purpose: Support-tool image processing for quantitative cardiovascular assessment and oncologic lesion evaluation, quantification, follow-up, and documentation to aid trained healthcare professionals in diagnosis; the software does not directly generate a diagnosis or potential findings.

Modality
CT/CTA; MRI
Anatomy
Heart and major vessels for Cardio AI; oncology lesion anatomy is not further specified in the FDA statement.
Decision
2020-03-25
FDA-cleared K193281

Hepatic VCAR

GE Medical Systems SCS

Authorized purpose: Analysis and visualization of liver CT data from DICOM 3.0-compliant CT scans to assess liver morphology and lesion change over time and to process, review, archive, print, and distribute liver CT studies.

Modality
CT/CTA
Anatomy
Liver, liver lobes, liver segments, liver lesions, and hepatic artery
Decision
2020-03-20
FDA-cleared K193267

Al-Rad Companion (Musculoskeletal)

Siemens Medical Solutions USA, Inc.

Authorized purpose: Provides quantitative and qualitative analysis of previously acquired CT DICOM images to support radiologists and physicians in musculoskeletal-disease assessment.

Modality
CT/CTA
Anatomy
Spine
Decision
2020-03-16
FDA-cleared K191550

Broncholab

Fluidda Inc.

Authorized purpose: Provides reproducible quantitative CT values for pulmonary-tissue diagnosis support and follow-up.

Modality
CT/CTA
Anatomy
Chest/Lung
Decision
2020-03-04
FDA-cleared K191125

ADAS 3D

Galgo Medical S.L

Authorized purpose: ADAS 3D post-processes contrast cardiac MRI and CTA to visualize and quantify myocardial scar and export reviewed results to electrophysiology navigation systems; it is not intended to identify ablation targets.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Heart/Cardiovascular
Decision
2020-01-15
FDA-cleared K191647

QLAB Advanced Quantification Software

Philips Healthcare

Authorized purpose: QLAB Advanced Quantification Software views and quantifies image data acquired on Philips ultrasound systems for professional review, including supported three-dimensional cardiac quantification functions.

Modality
Ultrasound
Anatomy
Structures represented in supported Philips ultrasound data, including cardiac structures
Decision
2019-12-20
FDA-cleared K192130

Icobrain

Icometrix NV

icobrain is intended for automatic labeling, visualization and volumetric quantification of segmentable brain structures from a set of MR or NCCT images. This software is intended to automate the current manual process of identifying, labeling and quantifying the volume of segmentable brain structures identified on MR or NCCT images. icobrain consists of two distinct image processing pipelines: icobrain cross and icobrain long.

Modality
MRI
Anatomy
Brain
Decision
2019-12-13
FDA-cleared K192531

QyScore Software

Qynapse

Authorized purpose: Automatic labeling, visualization, and volumetric quantification of segmentable brain structures and lesions from MR images, with comparison to reference percentile data; not intended for clinical scenarios requiring evaluation of the number of white matter hyperintensities.

Modality
MRI
Anatomy
Brain structures and lesions, including grey matter, white matter, hippocampus, amygdala, and white matter hyperintensities
Decision
2019-12-13
FDA-cleared K192571

NemoScan

Software Nemotec S.L.

NemoScan supports dental implantology by segmenting and transferring anatomy from CT or cone-beam CT images for implant and surgical planning.

Modality
CBCT
Anatomy
Dental/Maxillofacial
Decision
2019-12-11
FDA-cleared K191278

RSI-MRI+

MultiModal Imaging Services Corporation (dba HealthLytix)

Authorized purpose: RSI-MRI+ is indicated for use as automatic post-acquisition image processing software for analysis of diffusion-weighted and anatomical magnetic resonance imaging data. RSI-MRI+ is intended for automatic fusion of derived diffusion-weighted MRI data with anatomical T2-weighted MR images. RSI-MRI+ is additionally intended to provide automatic prostate segmentation, quantification, and reporting of derived image metrics.

Modality
MRI
Anatomy
Prostate
Decision
2019-11-19
FDA-cleared K191171

EchoGo Core

Ultromics Ltd

Authorized purpose: EchoGo Core automatically measures ejection fraction, global longitudinal strain, and left-ventricular volume from echocardiograms and reports the measurements to a clinician within the labeled workflow.

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2019-11-13
FDA-cleared K191026

MEDIP PRO

MEDICALIP Co., Ltd

Authorized purpose: MEDIP PRO is a software interface and image-segmentation system for transferring DICOM imaging information from a medical scanner to an output file and for preoperative treatment planning. Three-dimensional printed models generated from the output file are intended for non-diagnostic use, and the software is to be used with other diagnostic tools and expert clinical judgment.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Anatomy represented in CT or MR DICOM images for preoperative treatment planning
Decision
2019-11-07
FDA-cleared K192109

KOALA

IB Lab GmbH

Authorized purpose: The Knee OsteoArthritis Labeling Assistant (KOALA) software provides metric measurements of the joint space width and indicators for presence or absence of radiographic features of osteoarthritis (OA) on PA/AP knee X-ray images.

Modality
X-ray/Radiography
Anatomy
MSK
Decision
2019-11-05
FDA-cleared K183268

AI-Rad Companion (Cardiovascular)

Siemens Medical Solutions USA, Inc.

Authorized purpose: AI-Rad Companion Cardiovascular processes previously acquired CT DICOM studies to support quantitative and qualitative cardiovascular analysis, including heart segmentation and volume, coronary calcium, and aortic segmentation and diameter measurements.

Modality
CT/CTA
Anatomy
Heart, coronary arteries, aorta, and adult thorax
Decision
2019-09-10
FDA-cleared K183489

D2P

3D Systems, Inc.

Authorized purpose: D2P is a software interface and image-segmentation system for transferring DICOM imaging information from a medical scanner to an output file and is also preoperative software for surgical planning. The output may be used to produce a physical replica for adjunctive use with other diagnostic tools and expert clinical judgment in cardiovascular, craniofacial, gastrointestinal, genitourinary, neurological, and musculoskeletal applications.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Cardiovascular, craniofacial, gastrointestinal, genitourinary, neurological, and musculoskeletal anatomy
Decision
2019-08-29
FDA-cleared K191262

aBSI

EXINI Diagnostics AB

Authorized purpose: aBSI analyzes nuclear-medicine whole-body bone scans and SPECT to mark lesions and quantify skeletal disease burden as a fraction of total skeletal weight for trained professionals and researchers; the cloud release does not accept CT or static partial bone scans.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Bone
Decision
2019-08-05
FDA-cleared K183271

AI-Rad Companion (Pulmonary)

Siemens Medical Solutions USA, Inc.

Authorized purpose: AI-Rad Companion Pulmonary processes CT DICOM studies to support lung and lobe segmentation, measurements, density thresholds, and pulmonary-lesion segmentation, measurement, and lobe assignment.

Modality
CT/CTA
Anatomy
Lungs, lobes, pulmonary lesions, and adult thorax
Decision
2019-07-26
FDA-cleared K190017

LiverMultiScan (LMSv3)

Perspectum Diagnostics Ltd

Authorized purpose: LiverMultiScan LMSv3 is MR diagnostic software for non-invasive liver evaluation from abdominal MR images, including automated liver segmentation and proton-density fat fraction, T2 star, and corrected T1 measurements.

Modality
MRI
Anatomy
Abdomen including liver
Decision
2019-06-27
FDA-cleared K183593

Lung Vision System

Body Vision Medical Ltd.

The LungVision System is intended to enable users to segment previously acquired 3D CT datasets and overlay and register these 3D segmented data sets with fluoroscopic live X-ray images of the same anatomy in order to support catheter/device navigation during pulmonary procedures

Modality
CT/CTA
Anatomy
Chest/Lung
Decision
2019-04-18
FDA-cleared K183133

MRCP+ v1.0

Perspectum Diagnostics Ltd

Authorized purpose: MRCP+v1 is indicated for use as a software-based image processing system for non-invasive, quantitative assessment of biliary system structures by facilitating the generation, visualization and review of three-dimensional quantitative biliary system models and anatomical image data.MRCP+v1 calculates quantitative three-dimensional biliary system models that enable measurement of bile duct widths and automatic detection of regions of variation (ROV) of tubular structures. MRCP+v1 includes tools for interactive segmentation and labelling of the biliary system and tubular structures. MRCP+v1 allows for regional volumetric analysis of segmented tree-like, tubular structures and the gallbladder. Combining image viewing, processing and reporting tools, the metrics provided is designed to support physicians in the visualization, evaluation and reporting of hepatobiliary structures. These models and the physical parameters derived from the models, when interpreted by a trained physician, yield information that may assist in biliary systemassessment.MRCP+v1 is designed to utilize DICOM compliant MRCP datasets, acquired on supported MR scanners using supported MRCP acquisition protocols.MRCP+v1 is suitable for all patients not contra-indicated for MRI.

Modality
MRI
Anatomy
Abdomen
Decision
2019-01-09
FDA-cleared K182564

Quantib ND

Quantib BV

Authorized purpose: Quantib ND is software for the labeled brain MRI image-analysis workflow, providing release-specific visualization, measurements, or decision-support outputs for professional review.

Modality
MRI
Anatomy
Brain
Decision
2018-12-27
FDA-cleared K183012

vascuCAP

Elucid Bioimaging Inc.

Authorized purpose: vascuCAP analyzes contrast multidetector CT of arterial vessels to support atherosclerosis stratification with color maps, three-dimensional views, multiplanar reformats, and measurements for physician review.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2018-12-21
FDA-cleared K173749

AMRA Profiler

AMRA Medical AB

Authorized purpose: AMRA Profiler is MR diagnostic software for non-invasive fat and muscle evaluation, including liver fat fraction, T2 star, and muscle volume measurements from supported DICOM MR datasets.

Modality
MRI
Anatomy
Body including liver and skeletal muscle
Decision
2018-12-06
FDA-cleared K181939

icobrain

icometrix NV

Authorized purpose: icobrain segments and quantifies brain structures and lesions from MRI or noncontrast CT using cross-sectional and longitudinal workflows with acquisition-consistency limits.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Brain
Decision
2018-11-06
FDA-cleared K182616

NvisionVLE Imaging System, NvisionVLE Optical Probe, NvisionVLE Inflation System

NinePoint Medical, Inc.

Authorized purpose: The NvisionVLE Imaging System is an imaging tool for evaluating human tissue microstructure, including esophageal tissue microstructure, by providing two-dimensional, cross-sectional, real-time depth visualization and marking areas of tissue. The software provides segmentation and display of common imaging features including hyper-reflective surface, layering, and hypo-reflective structures. Safety and effectiveness for diagnostic analysis of normal versus a specific abnormality or disease have not been evaluated.

Modality
Optical Coherence Tomography
Anatomy
Human tissue microstructure, including esophageal tissue
Decision
2018-11-02
FDA-cleared K182034

Arterys MICA

Arterys Inc.

Authorized purpose: DICOM/non-DICOM image and data management with optional quantitative cardiac MR and oncology lesion evaluation, quantification, follow-up, and documentation support; the software does not directly generate a diagnosis or potential findings.

Modality
CT/CTA; MRI
Anatomy
Heart and major vessels for the optional Cardio AI module; lung and liver lesions or nodules for the optional Oncology AI module; the base viewer handles broader radiological image data.
Decision
2018-10-17
FDA-cleared K181892

Ziostation2

Ziosoft, Inc.

Authorized purpose: Ziostation2 is customer-hardware image-processing software for viewing, quantifying, manipulating, communicating, printing, and managing many radiological image types, with release-specific tools for lung and bronchoscopy planning, cardiac MR T1 mapping, and other advanced visualization.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Multi-region
Decision
2018-10-09
FDA-cleared K173444

Quantitative Total Extensible Imaging (QTxI)

AIQ Solutions, Inc.

Authorized purpose: QTxI manages and evaluates supported DICOM CT and PET studies, including registration, fusion, region-of-interest contouring, quantitative analysis, and evaluation of quantitative changes in the labeled workflow.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Multi-region
Decision
2018-07-23
FDA-cleared K173821

LungQ Software

Thirona Corporation

Authorized purpose: Provide quantitative support for physician diagnosis, follow-up examination, and documentation of pulmonary-tissue images or abnormalities from CT thoracic datasets.

Modality
CT/CTA
Anatomy
Thorax and lungs, including left and right lungs, lobes, pulmonary tissue, and fissures.
Decision
2018-06-05
FDA-cleared K173939

Quantib Brain

Quantib BV

Authorized purpose: Automatic brain-structure labeling, visualization, volumetric quantification, and WMH-candidate assessment as complementary information for trained professionals evaluating MR brain images and preparing quantitative reports.

Modality
MRI
Anatomy
Brain structures including grey matter, white matter, cerebrospinal fluid, intracranial volume, and white matter hyperintensity candidates
Decision
2018-03-09
FDA-cleared K180091

UNiD Spine Analyzer

Medicrea International

Authorized purpose: Assists healthcare professionals in viewing and measuring images and planning orthopedic surgeries, including generic and spine-related measurements, surgical planning, and implant-placement measurements.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Spine and anatomical components used for implant placement.
Decision
2018-02-08
FDA-cleared K173542

Arterys Oncology DL

Arterys Inc.

Authorized purpose: Oncology imaging workflow for viewing, manipulating, 3D visualizing, and comparing images and assessing/documenting morphological changes at diagnostic and therapy follow-up; supports lesion evaluation, quantification, follow-up, and documentation.

Modality
CT/CTA; MRI
Anatomy
Oncologic lesions, with semi-automated segmentation explicitly described for lung nodules and liver lesions.
Decision
2018-01-25
FDA-cleared K173588

Illumeo System

Philips Medical Systems Technologies, Ltd.

Authorized purpose: Illumeo is an image-management system for trained professionals, including radiologists. It is a software package used with general-purpose computing hardware to acquire, store, distribute, process, and display images and associated data throughout a clinical environment, including digital image processing, measurement, manipulation, quantification, communication, and storage. It is not to be used for mammography.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Images and associated data represented in the clinical environment; mammography excluded
Decision
2018-01-12
FDA-cleared K171328

cNeuro cMRI

Combinostics Oy

Authorized purpose: Automatically labels, quantifies, and visualizes segmentable brain structures from MR images.

Modality
MRI
Anatomy
Brain
Decision
2018-01-08
FDA-cleared K163623

Quantra

HOLOGIC, INC.

Authorized purpose: Quantra 2.2 analyzes digital breast X-ray images and categorizes breast density to provide additional information for a radiologist's assessment.

Modality
Mammography/DBT
Anatomy
Breast; mammographic breast-density composition
Decision
2017-10-20
FDA-cleared K172356

BladderScan Prime PLUS System

Verathon Incorporated

Authorized purpose: BladderScan Prime PLUS is a diagnostic ultrasound system with a bladder indication for noninvasive measurement of urine volume in the bladder using the supported probe and device configuration.

Modality
Ultrasound
Anatomy
Bladder
Decision
2017-09-15
FDA-cleared K170981

NeuroQuant

CorTechs Labs, Inc

Authorized purpose: NeuroQuant is intended for automatic labeling, visualization and volumetric quantification of segmentable brain structures and lesions from a set of MR images.

Modality
MRI
Anatomy
Brain
Decision
2017-09-07
FDA-authorized DEN170022

QuantX

Quantitative Insights, Inc

Authorized purpose: QuantX is breast MRI software for the labeled management, analysis, visualization, and decision-support workflow; exact image inputs, outputs, and use remain submission-specific.

Modality
MRI
Anatomy
Breast
Decision
2017-07-19
FDA-cleared K170172

UNiD Spine Analyzer

MEDICREA INTERNATIONAL

Authorized purpose: Assists healthcare professionals in viewing and measuring images and planning orthopedic surgeries, including generic and spine-related measurements, surgical planning, and implant-placement measurements.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Spine and anatomical components used for implant placement.
Decision
2017-05-24
FDA-cleared K163622

Lung Vision

BODY VISION MEDICAL LTD.

Authorized purpose: LungVision segments prior 3D CT and registers and overlays it with live fluoroscopic X-ray of the same anatomy to support catheter and device navigation during pulmonary procedures.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Pulmonary anatomy and catheter/device navigation targets
Decision
2017-05-11
FDA-cleared K163013

Quantib Brain 1.2

Quantib BV

Authorized purpose: Automatic labeling, visualization, and volumetric quantification of segmentable brain structures from MR images; visualizes and quantifies WMH candidates and provides complementary information for trained medical professionals evaluating MR brain images and preparing quantitative reports.

Modality
MRI
Anatomy
Brain structures, including grey matter, white matter, cerebrospinal fluid, and white-matter-hyperintensity candidates.
Decision
2017-01-06
FDA-cleared K161322

CT CoPilot

ZEPMED, LLC.

Authorized purpose: Automatically labels, visualizes, quantifies, registers, and reformats segmentable structures from CT brain images.

Modality
CT/CTA
Anatomy
Brain
Decision
2016-12-07
FDA-cleared K161148

icobrain

Icometrix

Authorized purpose: icobrain segments and quantifies brain structures and lesions from T1-weighted and FLAIR MRI using cross-sectional and longitudinal workflows with acquisition-consistency limits.

Modality
MRI
Anatomy
Brain
Decision
2016-08-09
FDA-cleared K153351

Quantib Brain 1

QUANTIB BV

Authorized purpose: Automatic labeling, visualization, and volumetric quantification of segmentable brain structures from MR images; visualizes and quantifies WMH candidates and provides complementary information for trained medical professionals evaluating MR brain images and preparing quantitative reports.

Modality
MRI
Anatomy
Brain structures, including grey matter, white matter, cerebrospinal fluid, and white-matter-hyperintensity candidates.
Decision
2016-06-17
FDA-cleared K142037

QUANTRA

HOLOGIC, INC.

Authorized purpose: Quantra version 2.1 calculates volumetric and area breast-density measures and density categories from supported digital mammography images as an adjunct, not a diagnostic result.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2014-10-10
FDA-cleared K141069

Lung Density Analysis

IMBIO LLC

Authorized purpose: Quantitative support for physician diagnosis, documentation, and follow-up examination of pulmonary tissue images and abnormalities from CT thoracic datasets

Modality
CT/CTA
Anatomy
Pulmonary tissue/lungs
Decision
2014-09-17
FDA-cleared K141480

CVI42

CIRCLE CARDIOVASCULAR IMAGING INC

Authorized purpose: cvi42 analyzes cardiovascular CT and MRI with MPR, MIP, volume rendering, centerlines, lumen and stenosis measurements, and reporting for qualified professionals.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Heart/Cardiovascular
Decision
2014-08-22
FDA-cleared K133649

HEPATIC VCAR

GE MEDICAL SYSTEMS SCS

Authorized purpose: Hepatic VCAR analyzes CT liver images to assess liver morphology and liver lesions with automated liver, lobe, segment, lesion, and measurement tools that a clinician can edit and confirm.

Modality
CT/CTA
Anatomy
Liver
Decision
2014-04-22
FDA-cleared K082483

QUANTRA

HOLOGIC, INC.

Authorized purpose: Quantra version 1.1 calculates a volumetric breast-density ratio from supported Hologic full-field digital mammography images on the Cenova server as an adjunct, not a diagnostic result.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2008-09-12